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“What does the brain matter compared with the heart?”
-Virginia Woolf, Mrs. Dalloway
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The Method of Madness: A Brief Biography of Schizophrenia
Introduction
I awoke that day much more uneasy that I had suspected. I was excited, but also
nervous in a way that I could not quite understand. When daunted by nerves, I tend to
handle grueling anticipation in a step by step fashion. Step one: get out of bed. Step two:
get in the shower. Step three: hair and makeup. Step four: hurry out the door, because at
this point I was inevitably behind schedule. The next step in line, was the familiar drive
to my Auntie Carol’s house. Auntie Carol is my father’s sister who is the kind of aunt
that feels much more like a second mother in many respects. I arrived at her home just
two minutes from her suggested time of arrival, an impressive feat. I stepped inside to
find her searching for our destination’s address on her ipad, and I recall finding it
somewhat odd that she was not exactly certain as to where her sister lived. Regardless,
we quickly pinpointed where we were headed on my phone’s GPS, and we were on our
way to visit my Auntie Carol’s sister, my Aunt Linda.
I grew up hearing lots of stories about Aunt Linda from my older cousins:
“remember the time she took it upon herself to cut Alex’s hair, and dad unleashed his
wrath?” or “she once sent me a birthday card with a 5 dollar bill and 2 dimes.” I am the
youngest of this generation, meaning that I did not have as much interaction with our
infamous Aunt Linda. In fact, I had grown up knowing little to nothing about my Aunt
Linda. In all of my 22 years on earth, I knew just one, fairly distinct thing about her--she
has schizophrenia.
I have known my Aunt Linda suffers from schizophrenia for quite sometime, long
before I had any understanding of mental illness. In fact, I can remember when my
mother told me about her illness, and I thought the word “schizophrenia” sounded so
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bizarre, so completely strange that however the illness afflicted Aunt Linda had to be
exceptionally bad, thus making her particularly weird. This rather simple thought process
remained steadfast throughout much of my youth. When I was about 9 year old, Aunt
Linda moved about an hour away to a group home, and I soon forgot about her existence
until I was reminded each year during the holidays when I received my annual, blank
birthday card from her. Her logic is that the blank card is the gift--so thoughtful, yet
somehow very psychotic. Once when I was about 16, she sent me a bottle of White Rain
shampoo for Christmas and my birthday. I distinctly feeling a little troubled by this,
because I could not understand how anyone could possibly think shampoo is an
appropriate gift.
The first time I ever learned any of the serious implications of schizophrenia was
during a lecture in intro psychology during my first semester at DePauw. I remember
schizophrenia was covered with an array of psychological disorders during the week that
we covered all of abnormal psychology. True to intro psychology, we barely skimmed
the surface of schizophrenia during the lecture: disordered thoughts, hearing voices,
significant genetic component, with symptoms arising in young adulthood. “Wait a
second...”, I thought, “I was in the throes of young adulthood, with a schizophrenic
aunt… Was I about to go crazy!?” Thankfully, my head remained clear of voices, aside
from my own. It was not until my junior year in a class called Evolution and Human
nature, that I would hear the word schizophrenia again. The class was examining how
psychological disorders like depression, anxiety, and schizophrenia persist in the
population, as they should be selected against by natural selection. I recall being
particularly interested in the section on schizophrenia in our assigned reading, as it

6

alluded that schizophrenia persists because relatives of schizophrenics often have
evolutionary advantages like increased intelligence and creativity. Not to toot my own
horn, but I wondered if this so called evolutionary advantage might apply to me? I have
always had a knack for all things artistic: drawing, scrapbooking, mosaics, ceramics,
painting, etc. Art class has always been my favorite. In addition to this, I have also
always had a certain knack for academics. In other words, I love to learn. Upon finishing
the section on schizophrenia in the reading, I was left dumbfounded: “is my academic
success due, at least partly, to my Aunt Linda’s illness?” This question lingered in my
mind for quite sometime. Like much of society, I knew only the bare minimum about
schizophrenia, basically only what I could recall from intro psych. Over the next few
months, I began to feel like I owed it to my Aunt Linda to learn about the illness that has
taken so much from her and has seemingly given so much to me.
Fast forward one year and Auntie Carol and I are on our way to visit Aunt Linda,
so that I could have a frame of reference for my honor scholar thesis. The weather that
day was beautiful, unusual for the end of Janurary, even by Indiana’s standards. On the
way, Auntie Carol and I had the standard conversation between relatives and college
students, “Yes, school is going fine.”, “I’ve been accepted as a corps member for Teach
for America”, and “No, there are no boys of interest as of yet.” After covering all the
bases, we began to discuss my senior thesis and just why I had requested to make this
visit. As we drove, Auntie Carol shared a lot about her childhood with Linda and how she
had always suspected that something was off, but her opinion was never given any
consideration, as she was just a child.
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When we arrived at the group home, I was extremely nervous. I had not a clue
what to expect, even after having read substantial literature on schizophrenics. I now
understand that this nervousness was just fear of the unknown. I had feverishly
speculated, “will she babble to herself?”, “will her laugh be weird or frightening?”, “will
she struggle with conversation?” I had no conceivable idea, but I was about to find out.
I soon found myself returning to the step-by-step method to calm my nerves. Step
one: get out of the car. Step two: go inside the building. When we opened the door to the
small facility we first had to check in with the staff. Auntie Carol politely stated, “Yes,
we’re here to see Linda Hawkins.” The staff was eager to meet us, particularly me. They
noted that she talked very frequently about her nieces. I found this heartbreaking, as I had
very rarely given her any thought or consideration before I started my thesis. The staff
directed us to the main living space. The dining room, living room, and kitchen of the
group home were each decorated in a manner that I can only describe as “grandparents
who had managed to update their home in the late 1990s”: beige walls, dated couches and
chairs, oak furnishings, a non-flat screen TV, and mass produced water colors adorned
the walls. The place really seemed to strive to embody a group home for the mentally ill.
After I had accessed the aesthetics, my eyes quickly found Aunt Linda eating her lunch at
the large dining room table. She immediately recognized Auntie Carol and I. Auntie
Carol introduced me, just to ensure she knew who I was, to which she responded, “yes, I
knew you were coming, but I was expecting Cathy not Riley.” There was no way she had
any conceivable idea that we were coming. The visit was something that had worked out
last minute, and who knows when the last time my cousin Cathy had talked to her.
Immediately I knew this was going to be a very interesting visit...
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Auntie Carol and I sat down to join her at the table. She was eating hominy, and
every bite seemed like it was carefully thought out. I soon realized it was because she did
not have her dentures in. Auntie Carol was very disheartened that she had dentures, as
they were due to the inevitable side effects of antipsychotics, causing her to lose her
teeth. Auntie Carol later told me that Linda had always taken very good care of her teeth.
As Linda ate her lunch, we began to have, for lack of a better word, normal conversation.
Auntie Carol lead most of their discussions, and I simply observed, taking it all in. They
talked about people they had went to school with, and I was quickly fascinated with the
fact that Linda was not missing a beat. She seemed to have a pretty powerful memory and
seemed genuinely interested in Auntie Carol’s gossip. Notwithstanding, moments later
she thanked Auntie Carol for a Danielle Steel novel that Auntie Carol had given her for
Christmas the year before, and it was shortly after this that I realized that Linda’s
psychosis is always at arm's reach. I asked, “Do you enjoy reading?”
She replied, “yes, I’ve been reading a lot lately.”
I asked, “what kinds of books do you read?”
To which she responded, “I really enjoy philosophy.”
Not expecting such an academic response, I questioned, “Really?”
She said, “Yes, I really like Plato and Aristotle.”
For all I knew, she might have actually been reading Plato and Aristotle, but then
I asked, “How many books have you read lately?” To which she said, “Oh, about 1 every
5 months or so.” It was then that I understood she was delusional. I quickly redirected us
from our philosophical conversation, but who knows, maybe Danielle Steele novels are
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just as difficult to read for her as Plato and Aristotle might be for an unbroken mind.
Ancient philosophy, romance novels--what's the difference, anyway?
After our inquisitive literature conversation, Auntie Carol began to explain to her
that I went to DePauw University, and I had received the Lilly scholarship for Orange
County. She explained to Linda that this was a full ride scholarship, and that she should
be very proud. Aunt Linda remarked, “Yes, college is very expensive. What is it about
$4,000 a year?” Auntie Carol and I both found this extremely comedic, but Auntie Carol
responded gently, “No, try about $50,000.” Aunt Linda was astounded, and I could tell
that schizophrenia had damaged her ability to interpret time. I puzzled if she understood
that it was 2016, not 1973. We made more small talk, and we soon made our way to Aunt
Linda’s room. Unsurprisingly, her room was an absolute disaster. Anything and
everything one could imagine was stacked on the floor, leaving a small path to her bed,
and her closet was full of God knows what. In the masses of what I can only describe as
junk, my eyes caught sight of a small, unicorn statue. The statue was painted with soft
pastels and had an iridescent glaze. It was the embodiment of a little girl’s imagination. I
told her I loved it and asked her where she got it. She began explaining that she had made
it with her dad when she was a little girl. Even if Auntie Carol had not been shaking her
head in disbelief, I could easily interpret that this was a delusion. Although I never met
my Grandpa Hawkins, as he died long before I was born, I could reason that he was
probably not the type of man to make unicorn statues. Nonetheless, I accepted her
delusional explanation and moved on.
Auntie Carol and I left shortly after the unicorn fiasco. We reasoned to Linda that
we hoped to visit more often and the next time we might go out for dinner. We
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exchanged our goodbyes and left the group home sans hugs, which seemed most unusual
to me but probably quite customary for Aunt Linda. Seconds later Auntie Carol and I
were out the door and headed home. Upon making it to the car, my head was buzzing.
What I had just experienced was similar to what one might feel after seeing a Van Gogh
painting for the first time in real life. One might learn that he made violent brushstrokes
and used vibrant colors, but prints cannot depict these characteristics of the originals.
They can only be appreciated by seeing the real thing. Similarly, I had been researching
schizophrenia for months, and having met someone with the disease after the research
was both awe-inspiring and fascinating--much like seeing a Van Gogh original for the
first time.
I had begun the day I visited Aunt Linda quite anxious about making the visit. On
the contrary, I went to sleep that night disheartened that mental illness, particularly
schizophrenia, is so misunderstood by society. I had come to understand that my Aunt
Linda, was almost like a normal person. While her delusions and disordered thoughts
made life more challenging for her, her illness does not hinder her day to day life. I now
understood, first hand, why experts in the field express such frustration with stigma.
Consequently, I want this thesis to take my experience with Aunt Linda and enlighten
those who might be fearful or ignorant to schizophrenia’s obscurities. Schizophrenia has
been at the forefront of scientific and political discovery, challenge, controversy, and
progress for centuries. This disease has an incredibly fascinating, interdisciplinary story
to tell, and I can only hope I do its story justice to help end societal stigma that has
victimized my Aunt Linda and so many others.
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This thesis will first explore schizophrenia’s early history, when and where does
madness first appear, and who were the pioneers that established the disease as we know
it today? This section will also analyze antiquated treatment methods, focusing on the
horrifying doctrines of the 20th century. Next I will introduce three accounts of
schizophrenia from three autobiographical accounts. They are taken from The Center
Cannot Hold by Elyn Saks, The Quiet Room by Lori Schiller, and Me, Myself, and Them
by Kurt Snyder. In this section I will describe what a schizophrenic diagnosis might look
like by examining each author’s early life up until their first or most dramatic psychotic
break. Next, I will describe the symptoms of schizophrenia while incorporating passages
from the autobiographies described above to help illuminate the severity of their effect on
day to day life. The next section will detail the etiology of schizophrenia. To some this
section might be considered dense; however, I encourage one to not be discouraged or
bogged down but retain inquiry, as the etiology of schizophrenia has an enormous
implication on its treatment and even its perception by society. As a biology major, this
section and the next on schizophrenia’s evolution are particularly fascinating, as much of
the engineering behind the human brain continues to remain elusive even to researchers
in the 21st century. The next section will cover the current treatment strategies of
schizophrenia, both medicinal and therapeutic. This section and the next will also include
personal insight from the autobiographies described above. Next, I describe only a
portion or perhaps the most common issues and injustices that schizophrenics continue to
face today despite advanced scientific research and improved treatment models. Finally, I
will use the stories of Elyn, Lori, Kurt, and my Aunt Linda to depict that a schizophrenia
diagnosis today should elicit hope, rather than fear.
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Establishing the Roots: Origins and Early History
Some experts contend that schizophrenia is a modern disease and has only arisen
within the last 200 years. While we have no definitive proof of schizophrenia’s origin,
there are accounts of madness that exhibit symptoms similar to schizophrenia dating all
the way back to the ancient Egyptians, Greeks, and accounts are further solidified in the
Middle Ages. With that being said, the formal description of schizophrenia has only
existed for about 150 years. Unsurprisingly, schizophrenia’s history is quite mystic, even
scary. However, what many find truly scary are the antiquated methods of treatment, not
the symptoms of madness. The outdated treatments highlighted with insight from antique
research papers are electroshock therapy, pre-frontal lobotomies, and psychoanalysis,
each being of common practice in the relatively recent history of the 20th century.
The Beginning
Some of the world’s oldest medical texts originate in Ancient Egypt. For example,
the Papyrus Ebers, a scroll projected to date back to 1500 BC, contains references to
mental conditions with associated diagnoses (Owen, 2014). These ancient academics
believed the heart and mind were the same entity. Therefore, the ancient Egyptians often
diagnosed most conditions that are now associated with the brain as diseases of the heart.
Nevertheless, these writings are some of the first to mention any disease associated with
the brain (Owen, 2014). It was not until 1100 years after the Papyrus Ebers were written
that Hippocrates described mental conditions as problems within the brain, not the heart.
Most ancient diagnosis of disease were summarized in a medical handbook,
written by the celebrated Greek physician Aretaeus around the second century AD. Many
of the classic symptoms of schizophrenia were depicted in Aretaeus’s book as conditions
of “mania” and “melancholy” (Owen, 2014). Aretaeus’s prescribed treatment? Humoral
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pathology, more often referred to as bloodletting. Humoral pathology is the idea that
diseases are caused by an imbalance of blood, phlegm, and black and yellow bile within
the body. Humoral pathology was also practiced by the Greek physician Galen who
influenced much of the medicinal philosophy and ideas of the Roman Empire. Galen, like
Hippocrates, attributed mental disorders as a brain disease--setting perhaps the earliest
foundation for the field of psychiatry (Owen, 2014).
Galen’s ideas influenced much of Europe throughout the Middle Ages; however,
Galen’s ideas based (somewhat) in science were at odds with the religious culture of the
time. Therefore, religious superstitions began to dominate the ideas and treatment of
mental health. Many Europeans believed that hallucinations and delusions were a cause
of demonic possession and witchcraft. Researcher and medical student Ruaridh Owen
postulates that witches were often forced to tell how they came to be possessed, and their
confessions were likely similar projections of the auditory hallucinations that are
experienced by paranoid schizophrenics even today, thereby making it possible that the
“witches” described in the Middle Ages were actually just individuals who suffered from
schizophrenia (2014). Exorcisms were the go to method of treatment in the 15th century
for mental illness.
Genesis of Terminology
In 1893, the term dementia praecox was made famous by the German psychiatrist
Emil Kraepelin. Kraepelin was the first to hypothesize that specific combinations of
symptoms in relation to the course of psychiatric illnesses allow one to identify a
particular mental disorder (Ebert & Bär, 2010) Meaning that he was the first to report a
distinction between manic depression and dementia praecox. Kraepelin considered
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dementia praecox as a biological illness caused by anatomical or toxic processes (Ebert
& Bär, 2010). Kraepelin used the term dementia because he believed that it was a
progressive and degenerative disease, which resulted in the irreversible loss of cognitive
functions. In contrast, he described manic depression as an episodic disorder, which does
not lead to permanent cognitive function (Ebert & Bär, 2010).
The word schizophrenia--which translates into “splitting of the mind” from the
Greek Roots schizein (“to split”) and phren (“mind”) was coined by Swiss psychiatrist
Eugen Bleuler in 1908 while at a meeting for the German Psychiatric Association in
Berlin. Bleuler liked the ideas of Kraepelin, but he wanted to make a novel distinction
(Ashok et al., 2012). In 1911, Bleuler wrote “I call dementia precox schizophrenia
because, as I hope to show, the splitting of the different psychic functions is one of its
most important features. In each case there is a more or less clear splitting of the
psychological functions: as the disease becomes distinct, the personality loses its unity.”
Bleuler first described the the main schizophrenia symptoms as 4 A’s: flat affect, autism,
impaired association, and ambivalence. Bleuler was first to notice that some patients
improve rather than deteriorate over time, thus the importance of moving aways from
degradation language proposed by Kraepelin (Ashok et al., 2012).
Antiquated Treatments
Early treatments of schizophrenia were restricted by a lack of knowledge of the
brain and the neurochemical aspects of the disorder. However, Bleuler and Kraepelin’s
early work seems to be established on better and certainly more ethical research then
much of what followed. Early 20th century treatments were crude and very under
researched, many of which lacked any scientific evidence. Combine these Frankenstein-
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like experiments with the asylum conditions reported in 1946 by Albert Q. Maisel in Life
magazine, and one is able to recognize just how far we have come in the way of treating
mental illness. One testimony from the Life issue came from a mental hospital in Ohio:
“An attendant and I were sitting on the porch watching the patients. Somebody
came along sweeping and the attendant yelled at a patient to get up off the bench
so that the worker-patient could sweep. But the patient did not move. The
attendant jumped up with an inch-wide restraining strap and began to beat the
patient in the face and on top of the head. 'Get the hell up...!' It was a few minutes
-- a few horrible ones for the patient -- before the attendant discovered that he was
strapped around the middle to the bench and could not get up."
Prefrontal Lobotomies
Prefrontal lobotomies were introduced by Egas Moniz in Portugal in 1936. Moniz
would somehow win a Nobel Prize in medicine for the introduction of the procedure. A
paper from the Journal of American Medical Association in 1943 notes that the
lobotomy, even at the height of their popularity, were considered a radical procedure that
should only be utilized on cases where all other treatment had failed (Bennett, 1943).
Bennett claims that a “definite change in personality occurs after lobotomies, noting that
patients become “more extraverted, less self-conscious, no longer aggressive, and
responsive to abnormal emotional drives, thus becoming a socially acceptable
individual.” Patients are also described as “childlike and cheerful” after the procedure.
The descriptions of socially acceptable, childlike, and cheerful violently contradict the
outcomes of these procedures, as patients were basically rendered completely helpless. A
procedure that utilized a modified ice pick, hammered into the eye socket and moved side
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to side to separate the frontal lobes from the thalamus should never have been described
as having “beneficial results” (Bennett, 1943).
The paper delivers 5 case studies of the procedure, all with varying degrees of
horror. One recounts a middle aged teacher who tried to stab her nephew. The case report
describes her as being “restless and resentful of hospitalization” (Bennett, 1943). She was
given 12 rounds of electroshock therapy before the lobotomy was performed. The
postoperative report reads, “The patient was untidy at first. Her belligerent and spiteful
remarks have changed to sarcastic and witty ones.” Her follow-up report comments, “She
has absolutely no insight but is able to make good social adjustment. She has been spared
institutional life and is a fairly useful, capable person.” One should be left wondering
how a person with “absolutely no insight” could ever be even “fairly useful”. The
remaining 4 case reports described in the paper are similar to this, often reporting
“carefree nature”, loss of memory, and weight gain.
Bennett’s report also describes the recovery period of these patients as regressive
to infantile levels, as the patient had to be fed and moved about in bed and they, quite
understandably, gave no attention to excretory functions. This despicable science
continues, “Some patients carry our repeated acts indefinitely, but gradually the patient
becomes more tidy” (Bennett, 1943). Contradicting most of these prior statements,
Bennett goes on to report, “the patient must be forced out of bed, taken to the toilet at
regular intervals, removed from the toilet, forced to bathe, dress, and feed himself.” The
paper concludes by suggesting that the degree of recovery cannot be determined until at
least 3 years after the procedure and that further research and study is needed for aid in
normal living post surgery. One can only imagine what life was like for, not only for the
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patient, but also the caregivers after those 3 years came and went. Thankfully, the use of
prefrontal lobotomies vanished with the advent of antipsychotics in the early 1950s.
Electroshock Therapy
Electroshock therapy was introduced in the 1940s, with the idea that inducing
seizures might improve psychotic symptoms. A 1946 case report from Harvard
University notes that, “judging from the patient’s behavior, the trembling, the profuse
sweating, and the impassioned verbal pleas for help and release, it would appear that
most patients find the treatment unpleasant.” If this is not disturbing enough, the report
continues by presenting this theory, “it has been suggested, for example, that the
treatment threatens the patient with death and offers him an opportunity of rebirth
cleansed of previous fears, anxieties, and confusions; or that, the treatment is a form of
punishment which absolves the patient from overwhelming guilt feelings.” This report
seems to keep true to the scientific theme of the time period, little evidence and a lot
emphasis on inducing punishment and guilt.
Following the introduction, the report gives a detailed, first hand account of a 24
year old manic college student’s experience with the therapy. Before the procedure began
he recounts, “there was another scream and a gurgling coughing groan, and the patient
ahead of me was moved down the hall into the dormitory, with arms, legs, and head
flopping around.” Not only was he able to witness the prior patient’s experience, but he
was also able to remember in striking detail his own experience:
“One held my right arm and pressured hard with the elbow just inside my
shoulder muscle. The other had the other arm. Another climbed the wagon and
laid across my knees--all three holding me down during my convulsion. The
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theory was: the more severe the convulsion, the better the results. I heard the
doctor give the pretty blonde nurse a set of numbers, and I knew she was setting
the dials. Very deliberately, very slowly a black shade came up over my eyes. I
woke up sometime later and could think of nothing” (Alper, 1946).
From the patient's account, we can gather that electroshock treatments were also a
monstrous attempt at treatment. Often times they were only truly successful at causing
large, blatant gaps in the memory of many patients.
Psychoanalysis
The 1950s were dominated by psychogenic theories of etiology. These were
theories that projected the idea that schizophrenia was caused by early problems in
interactions between a child and their parents. Psychoanalysis was often the go to
treatment, and at the time it was thought to be curative. Unlike today’s therapies that act
to change a patient’s thinking or behavior, psychoanalysis was based on assumptions and
projections to which there is no conclusive evidence to support. Below I present some of
the belief systems and models that helped guide this belief in a paper entitled, “Parents of
Schizophrenic Children Workshop, 1958.” This paper makes one wonder if those who
put any stock into the claims of psychoanalysis might have been just as delusional as the
schizophrenics they were attempting to treat.
The authors begin the paper by establishing that ego (the part of our personality
that prevents us from acting on our basic urges) disturbances within schizophrenic
children can be caused by either emotional or organic processes. The work further asserts
that in all the cases diagnosed as childhood schizophrenia, there was severe emotional
impairment arising from the emotional disturbances in the parent child interaction. The
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authors further claim, “that the schizophrenic child presents himself as a fragment of an
identity with distorted relation to reality” (Kaufman et al., 1958).
After establishing that the child’s schizophrenia arose from the disturbed
relationship between them and their parents, the authors further assert psychogenic ideas
by claiming that the parents of schizophrenic children had severe ego disturbances that
prevented them from mastering their fear of being overwhelmed by their primary
anxieties (Kaufman, 1958). This perspective believed that this fear was associated with a
fixation at the oral level of development, before the ego had developed “the usual
appropriate methods to cope with this threat.” According to Kaufman et al., psychosis
was supposed to protect the individual from being overwhelmed by anxiety, but it also
resulted in a loss of self-esteem. The idea here was that these defenses by the parents
created the range of parental personalities seen in schizophrenic children (Kaufman,
1958).
This paper suggests that regardless of external behavior (which can appear
adequate, i.e. they were actually good parents), these parents had a core ego disturbance
associated with “primitive destructive wishes and fears at the oral level of development.”
The authors assert that a diminished ego confused one variety of tension for another,
attempting to block life experiences to keep their anxiety at a tolerable level. Somehow
this was supposed to indicate that there was lack of differentiating between self from
nonself, and by not being able to distinguish between self and nonself, the parents
“projected their disturbance onto the child who became schizophrenic” (Kaufman, 1958).
According to this theory, the child became the embodiment of the parent’s underlying
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pathological process, and the child’s behavior exhibited the overly psychotic mechanisms
with which the parents were supposedly struggling.
As if the explanation for the child’s psychosis was not perturbing and far fetched
enough, the principal concept of treatment of these parents was the therapist's attempt at
“maintaining an awareness of the core disturbance and recognizing and dealing with its
expressions.” The authors note that this could be a long-term process that required “a
great deal of patience and understanding of how fearful and threatened these parents are.”
It is of particular interest to note that when the parent’s tried to present themselves as
adequate parents, the therapists took the parents’ pleas as defenses of the their selfesteem. This behavior by the parents was allowed early on in treatment, but it was
eventually unpermitted by the therapist in order “to ensure it would not blot out the
eventual discussion of pathologic material,” which was essentially the therapists trying to
make a feeble attempt at analyzing the early childhood of the parents. The language used
by these authors was unbelievably dense, as is evident from what has been presented.
One might question if this language was deliberately dense at an attempt to disguise just
how nonsensical it actually sounds: “schizophrenic children are the result of the inability
of their parents to deal with anxiety that arises due to the possibility of being weaned too
early as an infant.”
From what I have presented, schizophrenia’s history has been established as
particularly turbulent. However, it is important to understand the history of this disease
for several reasons: first, it is useful to look back and establish what treatments have not
been successful to ensure that ideas for new treatments draw from new ideas; to
recognize how far we have advanced, from bloodletting and exorcisms to dopamine
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antagonists; and finally, to understand how stigma might have been created so that it
might some day be fully eradicated.
From the Darkest Night: Diagnosis
The inner workings of madness cannot be fully understood without looking to
first-hand accounts, experiences, and journeys. Therefore, I will recount three stories of
obtaining a the same verdict: schizophrenia. Each story is unique, not only in its details,
but in the symptoms and demographics of its sufferer. First, I will recount Elyn Saks’s
journey from The Center Cannot Hold. Elyn’s account is unique because of her brilliance
and determination, as she has managed to acquire numerous academic degrees and is a
professor of law. Her primary symptoms are delusional thoughts. Next, I will deliver Lori
Schiller’s story from The Quiet Room. Admittedly, The Quiet Room is not an easy story
to read, as it recalls, with tremendous detail, the horrors of Lori’s thoughts and auditory
hallucinations. Next, I will draw from Kurt Snyder's narrative from his book entitled Me,
Myself, and Them. Kurt recalls his suffering of severe paranoid delusions. Each diagnosis
was unique, but the ultimatum associated with the diagnosis was all the same.
Elyn
Elyn Saks grew up in Miami, Florida to an affluent family. Her father was a
lawyer, while her mother stayed home, taking care of every want or need from her and
her two younger brothers. Elyn speaks very positively of her childhood, noting that it was
full of laughter, music, and movies. However, she notes that when she was about eight
years old, she began to do things a little differently, claiming that she developed “quirks.”
She goes on to say that not long after the quirks developed, she was joined by nights
filled with terror. She recounts that she knew someone was “just outside the window, just
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waiting for the right moment, when we were all sleeping, with no one left on guard. Will
the man break in? What will he do? Will he kill us all?” (Saks, 2007). Elyn details that
her first feelings of estrangement from the world began in high school, “I grew somewhat
quiet and withdrawn--’in myself’, as I came to call it. Unless spoken to, I didn’t have
much to say; I wasn’t sure I even deserved to be heard. I started to believe that speaking
was actually ‘bad.’”
As I mentioned earlier, Elyn was gifted with magnificent intelligence. She began
her education at Vanderbilt in Nashville. It was during her freshman year that Elyn
described the symptoms of schizophrenia “rolling in like a slow fog.” She notes that she
often forgot to take care of herself, meaning she went for long bouts of time without
showering or brushing her teeth, as the mind forgets to ask those sorts of questions, “have
you eaten today?” or “how often do I need to change clothes” (Saks, 2007). She speaks of
social isolation in the early days at Vanderbilt, eating many meals alone. She notes that
while she was at Vanderbilt she was constantly fighting to keep her shell strong, not
allowing any signs of illness break through. Fortunately, this strategy worked at this point
in her life, as she made straight A’s, taught herself to read Aristotle in the original Greek,
and she was awarded the Marshall scholarship to get a graduate degree in philosophy at
Oxford.
Elyn’s psychosis began to break through the shell she had managed to create
while at Vanderbilt in the first few weeks upon arriving at Oxford. She came extremely
delusional, citing that she often had difficulty differentiating between what was real and
what was not real. Elyn’s delusions were often on her unworthiness, “I am bad, not mad.
Even if I were sick, which I’m not, I don’t deserve to get help. I am unworthy” (Saks,
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2007). She had difficulty adjusting to the structure of Oxford courses, and she inevitably
fell behind. Consequently, she grew very depressed which led her to seek help. This was
the first time that she was suggested to be hospitalized. At first, she rejected the idea.
Then, recognizing that she was very depressed, checked herself into the day program at
Warneford Hospital so that she could get better in order to continue at Oxford. She notes
that at this time she felt, “only desperation and a profound isolation that every day
seemed to burrow more deeply inside me. What a waste of oxygen it was for me to draw
breath. Suddenly, the solution presented itself: killing myself. It seemed the best option”
(Saks, 2007).
Thankfully, Elyn got the help she desperately need at Warneford. She was quickly
admitted as an inpatient. She began to get consistent therapy and show signs of
improvement upon agreeing to take antidepressants. Nevertheless, she was eager to get
back to her studies at Oxford, and she left the hospital against medical advice.
Unsurprisingly, her symptoms returned and she was hospitalized for a second time.
During her second hospitalization is when her psychosis became much more severe. She
recounts,
“I began to feel I was receiving commands to do things--such as walk by myself
through the old abandoned tunnels that lay underneath the hospital. The origin of
the commands was unclear. In my mind, they were issued by some sort of beings.
Not real people with names or faces, but shapeless, powerful beings that
controlled me with thoughts (not voices) that had been placed in my head. Walk
through the tunnels and repent. Now lie down and don’t move. You must be still.
You are evil.” (Saks, 2007)
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Her illness began to command her to hurt herself. She burned herself with lighters,
cigarettes, electric heaters, even boiling water. Like many schizophrenic individuals, Elyn
did not tell the hospital staff about these symptoms. She adverts to a deep feeling of
embarrassment and shame. Elyn’s symptoms did not improve during her second
hospitalization; nevertheless, the hospital staff discharged her on the bounds that she
would begin a regimen of “serious talk therapy.” She was recommended to see a
psychoanalyst by the name of Elizabeth Jones, whom Elyn referred to as Mrs. Jones.
Elyn quite blatantly establishes that Mrs. Jones was not a counselor but an analyst full of
intellectual rigor. Personally, I cannot understand how one can find any solace in
psychoanalytic treatment for schizophrenia; notwithstanding, it worked very well for
Elyn and whatever works for someone, well works.
Once Elyn left the hospital and began to see Mrs. Jones regularly, she was able to
finish her philosophy degree at Oxford with her thesis receiving excellent reviews from
her examiners. Elyn stayed in England for a year after she graduated in order to continue
her analytic treatment with Mrs. Jones. During this year she actually volunteered at
Warneford Hospital and also decided to go to law school, landing on none other than
Yale.
It was during her first year at Yale that Elyn would have, what I would consider,
her most dramatic psychotic break. She not only dealt with the stress of a new
environment, but she refused to take any sort of medication. The fog of madness soon
settled in. While visiting a professor during his office hours, she climbed out his window,
onto the roof of Yale Law School. She recalls the outburst of madness,
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“I spent the next hour or so laughing and singing and gibbering away on the roof
of the Yale Law School. I found several feet of loose telephone wire up there, and
made myself a kind of belt. I picked up all sorts of metal objects lying around on
the roof and attached them to the belt. The best find was a rather long nail, six
inches or so. I put it in my pants pocket, just in case I needed protection” (Saks,
2007).
While with the same professor, she called an old friend from Vanderbilt’s neurologist
husband, Richard. The conversation went a little something like this, “Elyn, is something
wrong?”, Richard asked. “Come to the Florida sunshine tree,” she replied.
He asked, “What do you mean?”
She babbled back, “Fresh tasting lemon juice naturally. There’s a natural volcano.
They put it in my head. It’s erupting. I’ve killed lots of people. I’ve killed
children. There’s a flower on the bookshelf. I can see it blooming. Have you
killed anyone, Richard? My teacher is God. I used to be God but got demoted. Do
you think it’s a question of Kilimanjaro?”
Richard urged her professor to take her to the hospital immediately and soon after she
was taken to Yale-New Haven Hospital, before she was quickly transferred to Yale
Psychiatric Institute.
While in YPI, Elyn reports in astonishing detail the atrocity she experienced:
being placed in restraints for hours on end with medicine being shoved down her throat.
One should speculate how on earth this kind of treatment happened was allowed to
happen in the United States? Like any human being who is forced to succumb to such
blatant, detrimental treatment, Elyn fought back against the restraints in anyway she
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could--screaming, humming Beethoven, begging and pleading. She also made several
escape attempts, landing her right back in the restraints. Elyn received her first formal
diagnosis during this hospitalization--chronic paranoid schizophrenia with acute
exacerbation.
Lori
Much like Elyn, Lori Schiller was a bright, young girl when she was thrown into
war with madness. Lori notes an exceptionally happy childhood, filled with love,
comfort, and friendship. She adds that when growing up she had always felt special, she
was the oldest and the only girl. She loved attention, and to get it she strove for the
highest achievement. Lori describes her onset of psychosis as having a pleasant
beginning, “Sometime during that summer things began to change. At first, the change
was pleasant. Somehow, without my quite knowing why, everything seemed much nicer
than it had been before. The lake seemed more blue, the paddlewheels bigger and the
sailboats more graceful than ever before” (Schiller, 1996). She was at summer camp, and
everything seemed right with the world. Nevertheless, her “mood began to shift, and the
brightness of the world began to darken. Then came the dreadful thoughts.” She recalls
that her mood began to “turn black,” and a dark haze settled around her. Perhaps the most
enlightening account of the experience, “Then, in the middle of this chaos, a huge Voice
boomed out through the darkness. ‘You must die!’” Upon returning home from camp, she
kept the voices to herself. During her last year of high school the Voices came and went
without warning, but ultimately she had more good days than bad during this infantile
stage of psychosis.

27

She enrolled in the prestigious Tufts university, and on the surface everything was
going well for her. She had lots of friends, a vibrant social life, and did well in her
classes. On the inside, however, the Voices were becoming louder and faster. She adds
that they filled her with anxiety, and she was always tense. She laments,
“What tortured me more than anything was when the Voices laughed at me. It
was kinds of hysterical laughter, as if I was the target of everyone’s jokes. I didn’t
know why they were making fun of me so viciously but I hated myself for being
the sitting duck of ridicule. I became extremely self-conscious in front of
everyone for fear that they too would nail me to a taunting cross” (Schiller, 1996).
During this time Lori’s “highs were higher” and her “lows lower.” Self harm entered her
mind: “I thought increasingly about hurting myself. I sat in the library, up all those flights
of stairs, and considered jumping” (Schiller, 1996). At this point, she clearly knew
something was wrong, “something was about to snap.” She began meeting with a
counselor at Tufts and a psychiatrist every week in a private practice, but she never
brought herself to mention the Voices.
After graduating from Tufts, Lori moved into an apartment in New York City
with a close friend. She had a great job in the city, but things began to unravel quickly,
and within months she had attempted suicide for the first time. Her psychosis quickly
spiralled out of control. She was hospitalized for the first time, but with the help of her
concerned father, she was released quickly without any evidence of a psychotic break on
her record. Even so, when Lori returned home she was unable to retain a job, her friend
had moved out, and her apartment became a disaster. She smoked cigarette after cigarette
to pass the time, to ease the pain of psychosis. Soon, her parents enrolled her in a clinic
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that specializes in psychopharmacology, essentially a program that prided itself in
loading up its consumers with potent drugs. Soon after this development came her second
suicide attempt and second hospitalization.
Upon her second hospitalization, Lori was transferred to The Payne Whitney
Clinic of New York Hospital, a place that specialized only in short-term psychiatric
problems. Her father remembers that the first time he saw the hospital he understood that
it “was no ordinary place where ordinary people came to get well.” When Lori’s father
saw her in this environment for the first time he bemoans, “I saw my daughter. But it was
not my daughter. The Lori I knew was gone. And in her place was a stranger, a person
who seemed to be living only partly in this world, and partly in some faraway world of
her own making… The illness had captured her, and was apart of her” (Schiller, 1996).
The Quiet Room offers insight from medicinal notes on Lori from this time
period. A primary therapist penned,
“Patient remains agitated and intermittently actively hallucinating. It became
clearly evident in discussion how tormented she is by these voices and how hard
she is fighting to resist their commands. Much of her treatment resistance appears
to stem from fear of the repercussions of revealing these hallucinations to staff.
‘They’ll kill me if I tell.’”
Lori’s mother visited her daily while she was in the hospital. Her mother remembers Lori
was often in a fog, “as if a curtain were drawn between us.” Her mother expresses
frustration in The Quiet Room that after Lori had in the hospital for quite some time, they
still were not aware what was wrong with her and they had tried every cocktail of
antipsychotics imaginable: “They gave her enough medicine to fell a cow. But nothing
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was working.” After Lori had been at Payne Whitney for two months and had even
surrendered to electroshock therapy, the doctors believed they had a better idea of what
Lori’s problems were. They soon delivered her diagnosis to her parents, “Because of the
combination of her severe mood swings and her hallucinations we think that Lori has
something called schizo-affective disorder. She’s got some symptoms of schizophrenia
and some symptoms from manic-depression” (Schiller, 1996). Her parents, quite
understandably, were devastated by her diagnosis. They had difficulty accepting that she
would never get better, so they fiercely contested the doctors’ opinions. One young
doctor in the room took it upon himself to fire back at them, “Schizophrenia is a serious
illness. It may be a very long time--if ever--before she will get better. She will probably
never be able to live on her own again. It would be better for both of you if you faced
facts” (Schiller, 1996).
Kurt
Kurt Snyder also had a normal childhood. He tells of his parents’ kindness and
encouragement in everything he did, from school to sports. He incites that he did not
have many friends his age, but had a few close friends and that was enough for him.
Like the others, Kurt's symptoms arose with the stress of college. He recalls,
“everything fell apart during my second semester, when I became disorganized, lost in
my concentration during class, and failed to complete many of my homework
assignments. I ended the year with very poor grades” (Snyder, 2007). He remembers that
during his first year he began to believe that he was going to discover a new
mathematical principle that would transform the way we view the universe. Of the
experience he says, “I told myself I was always on the verge of discovery, and I hadn’t
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discovered the right idea because I just wasn’t thinking hard enough. I knew it would take
a genius to solve some of the problems I was thinking about, but I didn’t realize that I
wasn’t a genius” (Snyder, 2007). Kurt began to struggle academically, and soon dropped
out of college. He planned on starting his own business, but that failed as well. He further
established himself as a “professional handyman.”
During this stage he began to feel more and more self-conscious, wondering if
people were watching him while he worked. He remembers that the paranoia began
mildly, meaning that he only wondered if his clients were watching him. It would not be
until he fell deeper into illness that he actually believed they were watching him. He
recalls that it was also during this time that he began to fear security cameras, especially
the ones found in large megastores, banks, and convenience stores. He elicits, “They
made me feel like I was being watched exclusively. As more time passed, I started to get
a general feeling that I was being observed wherever I went, by the general public. I felt
exposed and self-conscious in every public place--like I was on display at the zoo”
(Snyder, 2007). Kurt soon sought the help of a psychiatrist but was unable to allow
himself to speak about his paranoia.
Several months later, Kurt got a new job as a maintenance man at a high-security
building. This obviously led to more frequent feelings of paranoia, and soon his mind
filled with delusions. He attests, “I quickly became convinced that the FBI had hacked
my computer, and they were somehow working with the facility to keep me under
surveillance. I certainly didn’t have any real evidence of this, but evidence isn’t required
for a delusion” (Snyder, 2007).
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Kurt’s psychotic break happened quite abruptly. He unravelled quickly. On the
way home from his brother’s house one Sunday he remembers that he started to think
about religion and began to believe that he had “joined the universe on some
metaphysical level.” He wondered if he was God. On the drive back from his brother’s
house he also began to believe that FBI agents were following him as well. He soon
drove to his place of work, looking for his boss whom he believed was in on an operation
with the FBI against him. When he arrived at his place of work, he had an altercation
with the security guard on duty and ran away on foot. For there he recounts,
“I called a taxi at a nearby hospital. My plan was to take public transportation
back to Maryland from DC, and call my folks to come pick me up. I was highly
agitated and suspicious of everyone. When the taxi driver arrived, I gave the
driver very specific instructions--I was even suspicious of him. He drove for
about 5 miles before turning off the route that I had given him. ‘Where are you
going?’ I asked ‘I know a shortcut,’ he said. I began to think, ‘He must be with
Them! He’s kidnapping me!’ I asked, ‘Are you going to kill me?’ Not waiting for
a response, I bailed out of the cab at the next stoplight” (Snyder, 2007).
After getting out of the cap he began to walk along the highway. Soon his boss found
him, as the security guard had notified him that Kurt was frantically looking for him. At
this point, Kurt definitely thought that his boss was working against him, and he ran away
from him. Kurt’s boss called the police and soon sirens were behind Kurt while he was
walking along a highway. Quite understandably, the police wanted to know why he was
running along the highway and why he left his truck at his work place. Kurt somehow
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convinced the police that he was fine and managed to get them to take him to the airport
so he could catch a bus at the metro station.
Kurt got on various buses and trains thereafter, attempting to “lose the agents”
that he believed were following him. He eventually arrived at a train station in Maryland
and called his parents to pick him up. They had already spoken to Kurt’s boss, and were
finally fully aware of the extent and severity of his mental illness. They scheduled an
appointment with a psychiatrist, but Kurt told him very little about his delusions. This
psychiatrist incorrectly diagnosed Kurt with bipolar disorder, a not uncommon
occurrence.
An Abnormal Reality: Symptoms
As evidenced from the previous accounts, there is no single symptom that is
found only in schizophrenia. This makes diagnosis particularly tricky, hence the
psychiatrist who incorrectly diagnosed Kurt. The DSM criteria for schizophrenia requires
that there are two or more of the following symptoms present for a significant portion of
time during a one month period: delusions, hallucinations, disorganized speech, catatonia,
restricted affect, and asociality. In this section I will describe the most common
symptoms of schizophrenia: alterations of senses, inability to interpret and respond,
delusions and hallucinations, changes in emotions, and anosognosia. Positive symptoms
are considered those that add to the disease, hallucinations and delusions. Negative
symptoms are those that disease takes away, inability to interpret and respond. I will
highlight an example of some of these symptoms that were experienced by either Elyn,
Lori, or Kurt in order to illustrate how that symptom might appear in an individual
context. The descriptions of the symptoms are taken from Surviving Schizophrenia by E.
Fuller Torrey. Torrey is a psychiatrist who has written numerous books, conducted loads
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of studies, and prepared numerous reviews on all things schizophrenia. It is worth
mentioning that his sister suffered from illness as well. With that being said, if anyone
understands the symptoms of schizophrenia, it is Torrey.
Alterations of the senses
Torrey asserts that alterations of the senses are especially prominent in the early
stages of breakdown in schizophrenia, and that they can be found in almost two-thirds of
all patients. In some instances visual alterations improve the appearance of something.
Sometimes both hearing and visual sensations are increased. This is evidenced by Lori
Schiller’s onset of schizophrenia, “Everything seemed much nicer than it had been
before” (Schiller, 1996).
Closely related to the over acuteness of the senses, is the flooding of the senses
with stimuli. It is not only that the senses become more sharply attuned but also that
schizophrenics see and hear everything. Under normal circumstances our brain screens
out most incoming sights and sounds, allowing us to concentrate on whatever we choose.
This screening mechanism is impaired in many people with schizophrenia, thereby
releasing a flood of sensory stimuli into the brain simultaneously (Torrey, 2013). Kurt
experiences this symptom. He recalls in Me, Myself, and Them, “I became acutely aware
of certain stimuli that normal people don’t notice. Noises like fans, people coughing, car
horns, machinery rattling, tires screeching, wind blowing, engines running, and birds
chirping became very disturbing to me” (Snyder, 2007) On this experience Ely Saks also
relates,
“Consider this: The regulator that funnels certain information to you and filters
out other information suddenly shuts off. Immediately, every sight, every sound,
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every smell coming at you carries equal weight; every thought, feelings, memory,
and idea presents itself to you with an equally strong and demanding intensity.
You’re receiving a dozen different messages in a dozen different media--phone, email, TV, CD player, a friend knocking on the door, ideas inside your head--and
you’re unable to choose which ones come to the front and which are regulated to
‘later.’ It’s the crowd at the Super Bowl, and they’re all yelling directly at you”
(Saks, 2007).
Furthermore, it obviously becomes difficult to concentrate or pay attention when
so much sensory data is rushing through the brain. One study reported more than half of
the people with schizophrenia reported impairments in attention (Torrey, 2013). Elyn
sights this experience in her early days at Oxford, “I could not concentrate on my
academic work. I could not understand what I was reading, nor was I able to follow the
lectures. And I certainly could not write anything intelligible” (Saks, 2007).
Another aspect of the over acuteness of the senses is a flooding of the mind with
thoughts. It is as if the brain is being bombarded both with external stimuli and with
internal stimuli. A variation of flooding with thoughts occurs when the person feels that
someone is inserting the flood of thoughts into his or her head. This is commonly referred
to as thought insertion and when present is considered by many psychiatrists to be almost
certainly a symptom of schizophrenia (Torrey, 2013). This phenomenon happened to
Kurt just before his first psychotic break,
“My imagination was running wild. I was thinking about how computer systems
had become more powerful in the last 50 years. What impossible tasks would
become possible in the future thanks to computer technology? I wondered if
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computers would be able to send data directly to the brain by some type of neural
connection. Could such a computer generate a virtual reality? Maybe I was
hooked up to one right now! Maybe my whole world was actually generated by a
virtual reality machine connected to my brain” (Snyder, 2007).
However, some patients describe the sensitivity as pleasant in the earliest beginnings of
the disease. Many patients interpret their newfound sensitivity within religious
framework, that they have been touched by God.
It is worth noting that sensations are not always enhanced. The can be blunted, as
well. Blunting often occurs late in the disease and is often described as “a heavy curtain
drawn over the mind.” One sensation that can be be blunted in some rare cases is pain.
Some attribute pain blunting to antipsychotic medication side effects, but the effect has
been described long before the advent of these medications (Torrey, 2013).
Inability to Interpret and Respond
Torrey cites that in normal people, the brain functions to sort and interpret stimuli,
followed by a correct response being selected and sent out. Most responses are learned
and often include basic logic like simply being able to predict outcomes of your actions.
A hallmark of schizophrenia is the inability of the brain to sort, interpret, and respond
(Torrey, 2013). Many schizophrenics also struggle with putting auditory and visual
stimuli together. Recall that not being able to select an appropriate response to stimuli
was the symptom that supposedly led Eugen Bleuler to coin the term schizophrenia, as he
attributed these odd responses to a split mind (Torrey, 2013).
The schizophrenic thought process is often described as disconnected. The terms
loosening of associations, impairment of logic, thought blocking, and ambivalence are
often used by psychiatrists. Patients often put together several disconnected ideas that a
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normal functioning brain could not come up with. Often schizophrenics make vague
connections between their jumbled thoughts, this is what is referred to as loose
associations (Torrey, 2013). Kurt’s symptoms often took the form of loose associations.
For example, Once while sitting on a bench, a large bug landed on a bush near by him,
causing him to think about hidden microphones being called “bugs” and about insects
being called “bugs.” He quickly began to believe that the bug that had landed nearby was
a surveillance device designed by the CIA to look like a real insect (Snyder, 2007).
Another uncommon but dramatic form of thinking in schizophrenia is called word
salad; the individual just strings together a series of totally unrelated words and
pronounces them as a sentence. Elyn Saks’s symptoms frequently appeared as world
salad. Once when on the phone with one of her therapists she said, “Yes, but it’s Sunday.
The Sundance kid. Bearded and gray. With all the interferences” (Saks, 2007). Naturally,
he knew she was having a psychotic break and he urged her immediately into his office.
Another classic symptom of schizophrenia is flattened affect. Often these
individuals seem very aloof and often respond incorrectly or abnormally. A classic
example of this comes to my mind via my Aunt Linda. When her siblings called to
inform her that their eldest brother had passed away, she simply responded with, “Well, I
guess that happens sometimes,” and hung up the phone.
Torry asserts that it is an unusual patient who does not have some form of
thinking disorder. Some psychiatrist even question whether schizophrenia is the correct
diagnosis if the person’s thinking patterns are completely normal.
Delusions and Hallucinations
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The best known symptoms of schizophrenia are hallucinations and delusions.
They are dramatic and are often the behaviors usually focused on when schizophrenia is
being represented in popular literature or movies (Torrey, 2013). It should be
remembered that these symptoms are not essential to schizophrenia, as there are many
schizophrenics who suffer from other symptoms like thought disorder that do not report
hallucinations or delusions. These symptoms are also found in other brain diseases aside
from schizophrenia; therefore, they are not complete hallmarks of the disease. It is also
important to understand that most delusions and hallucinations are distortions of the body
boundaries; they are direct outgrowths of over acuteness of the senses and the brain’s
inability to interpret and respond to stimuli. They are the culmination of the other
problems the brain is experiencing.
Delusions are a false idea believed by the patient but not other people in his/her
culture and that cannot be corrected by reason. They are usually based on some sort of
sensory experience that the person misinterprets. One common delusion is that random
events taking place around the person all relate in a direct way to him or her. The suffer
often knows his or her delusions to be true with absolute certainty; therefore, trying to
reason with them often leads nowhere (Torrey, 2013). Elyn Saks had delusions that she
had killed thousands of people, even children, with her thoughts. Kurt Snyder suffered
from the common delusion that he was being watched by the FBI. Paranoid delusions,
like Kurt’s, can sometimes be dangerous, as a paranoid person may try to strike first if
they feel a threat. Many delusions are grandiose. This often leads to the person believing
he or she is God, Jesus Christ, the President, etc. These delusions can be dangerous but
often only to the sufferer, as they might believe they are indestructible. Lori Schiller was
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convinced that she had the ability to fly: “I know you’re not going to believe this, Daddy,
but I can fly. I can fly. Really, Daddy. I can” (Schiller, 1996). She then began to
demonstrate her flying by jumping off sofas and even suggested her father take her to a
window to show her new found ability to fly.
Hallucinations are very common in schizophrenia and are at the very end of that
spectrum that begins with a slight sensitivity to the senses. In true hallucinations the brain
makes up what it hears, sees, feels, smells, or tastes (Torrey, 2013). Auditory
hallucinations are the most common form. The hallucinations may be heard occasionally
or continuously. In a vast majority of cases, the voice are male and very unpleasant.
Visual hallucinations often occur in conjunction with auditory hallucinations. Lori
Schiller's hallucinations in The Quiet Room absolutely qualify as unpleasant. She recalls
that The Voice’s power over her was “too fierce.” She says that there was nothing on the
outside that could pull her away. They were the most powerful thing in her world
(Schiller, 1996). She asserts that the closest she ever got to hearing a friendly voice was
what she referred to as the narrator:
“He described my actions instant by instant, not leaving out even the tiniest, most
insignificant thing. A hundred times a day, he commented on my movements.
‘She is now walking through the door. She’s wiping her feet, little ass. Wiping her
feet on the rug in the entryway. She’s going into the kitchen. Ha! Ha! You fat
piece of lard, of lard. Go to hell. Ha! Ha! You look sad. You look like a shit. You
are shit’” (Schiller, 1996).

39

She tells that sometimes that voices instead joined together in a large congregation,
always reminding her that she was going to hell. As Lori’s disease progressed she also
suffered from visual hallucinations. Again in vivid, bone-chilling detail she remembers,
“But the worst torment in those days was not the things I heard but the things I
saw. I saw fire, lightning, colored bolts of light. I saw people hanging in the
window, and body parts hanging from the trees. I saw fire around people and
walls and faces. Sometimes I felt I had projector eyeballs, shooting things and
shapes and colors straight ahead of me. Sometimes I saw things that looked as
real as my bed or my lamp or my tennis shoes.
I couldn’t sleep at night because of the creatures in my bed. I sat at my
desk writing in my journal one night because I was afraid to go near my bed.
‘There are four of them sitting on my bed,’ I wrote. Usually I saw creatures with
faces that were like the scariest Halloween mask ever made or creatures with big,
blubbery, hairy, slippery green faces” (Schiller, 1996).
Changes in Emotions
According to Torrey, changes in emotions is often one of the most common
characteristics. In the early stages of the illness, depression, guilt, fear, and rapidly
fluctuating emotions may all be found. In the later stages, flattening of emotions are more
common, often resulting in people who cannot feel emotions at all. Elyn, Lori, and Kurt
all experienced very deep depression and fear at the onset of their illness. Often many
schizophrenics have difficulties in assessing emotions in other people. The most
characteristic changes in emotions in schizophrenia are inappropriate or flattened
emotions (Torrey, 2013).
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Anosognosia
Some people with schizophrenia are aware of the malfunctioning of their brain;
this is called awareness of illness or insight. As the disease becomes fully manifest this
awareness is lost. This if often why patients stop taking their medication. They begin
medication, start feeling better, then stop believing that they are sick, like this illness is
some kind of flu virus. They are certain they are fine, when in reality the medication is
lifting the fog of psychosis. It took Elyn Saks a very long time to understand this: “If I’d
had a broken leg and a crutch was required, I’d have used it without ever thinking twice.
Was my brain not worth tending to at least as much as my leg? The fact was, I had a
condition that required medicine. If I didn’t use it, I got sick; if I used it, I got better. I
don’t know why I had to keep learning that the hard way, but I did” (Saks, 2007).
The Method Behind the Madness: Theories of Etiology
The etiology of cancer is well understood. It is, with a few exceptions, a disease
of old age. The etiology of schizophrenia, on the other hand, has been a minefield of
discovery. First, genetics were believed to be the sole cause. Scientists once, almost
laughably, believed that a single gene could be responsible for such a complicated
disease. Next, came the neuropathology hypotheses, then neurotransmitter theories, then
developmental theories, then bacterial theories, and so on. Finally, scientists have
reasoned that the rise of schizophrenia is most likely the culmination of all the
implications of these theories working in combination with environmental variables to
create this bemusing illness that has eluded scientists for centuries. To put it simply, the
etiology of schizophrenia is complicated. Next, I will only scratch the surface while
summarizing the genetic, neurochemical, pathological, developmental, and infectious
properties of the disease.
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Genetic Theories
While there is a lot of dispute as to the number of genes involved in this process
and their subsequent effects, there is little to no doubt that there is a genetic component of
schizophrenia. Relatives of patients with schizophrenia have a 5-10 times increased risk
for developing schizophrenia compared with the general population. Heritability for
schizophrenia has been estimated at 80%, and linkage or gene-disease associated studies
have found some loci that are likely associated with schizophrenia on chromosomes 1, 2,
3, 5, 6, 8, 10, 11, 13, 14, 20, and 22 (that is 12/23 chromosomes). Data from association
and linkage studies have confirmed that schizophrenia is NOT caused by a single gene.
Instead it is what geneticists refer to as polygenetic. Each gene responsible has a small
effect, and can even have different or contrasting association results (Olgiati et al., 2009).
Endophenotypes have emerged as promising targets of psychiatric genetics. The
term endophenotype is currently used in psychiatric research to define a measurable
biological or psychological trait that is common to both individuals with a disease and
their non-affected relatives and that may predispose to illness onset (Olgiati et al., 2009).
Researchers Olgiati et al. defined an endotype as a neuropsychological or
neurophysiological character associated with schizophrenia. They are heritable, stable,
and trait related. These researchers report that schizophrenia-related endophenotypes are
cognitive functions such as attention, working memory, executive functions, and
visuospatial memory that are impaired in schizophrenic patients and that can also be
impaired in their non-schizophrenic relatives. Below are descriptions of the most
common genes associated with schizophrenia: COMT, Neuregulin 1, DISC-1, DTNBP1,
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and GRM3. The effects of these genes and their endophenotypes are described for both
schizophrenic individuals and their non affected relatives.
Catechol-O-methyltransferase (COMT)
This enzyme terminates catecholamine activity in the brain by degrading
neurotransmitters. The gene that encodes COMT has a functional polymorphism (Val
108/158 Met) that moderates dopamine availability in the prefrontal cortex in an allele
dependent manner. The Met allele, which has 3-4 times lower enzymatic activity, has
been associated to higher dopamine levels in the prefrontal cortex (the region of the brain
most associated with planning complex cognitive behavior). There have been a number
of studies that have indicated this COMT polymorphisms as a risk factor for
schizophrenia. The Val-allele has higher enzymatic activity, resulting in lower prefrontal
cortex dopamine levels (Olgiati et al., 2009). The Met-allele has lower enzymatic levels,
resulting in higher dopamine levels. Altered dopamine levels have long been associated
with the pathology of schizophrenia and can also have effect on non affected relatives.
Neuregulin 1 (NRG1)
The neuregulins (NRGs) are cell-cell signalling proteins that are ligands for
receptor tyrosine kinase family (proteins that regulate normal cellular processes) of the
ErbB family (improper signalling in this family has been associated with the onset of
many neurological disorders). NRG1 proteins have been shown to play important roles
during the development of the nervous system. Therefore, these findings help support
NRG1’s involvement in the pathogenesis of schizophrenia (Olgiati et al., 2009).
Disrupted-In-Schizophrenia 1 (DISC-1)
This gene is disrupted by a balanced translocation that has been shown to
cosegregate with major psychiatric disorders. The DISC-1 protein occurs in various
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subcellular compartments, including the centrosome, microtubules, mitochondria, and the
nucleus. Recent studies have established that DISC1 is a component of a
neurodevelopmentally regulated protein complex that has different functions in the
developing and the adult brain. In the developing brain, DISC1 has been implicated in
neuronal migration and in outgrowth and extension. In the adult brain, DISC1 has been
identified in multiple neuron populations, particularly in structures that specialize in
synaptic function (Olgiati et al., 2009). DISC1 is also present in many of the brain
regions that are known to be abnormal in schizophrenia--the prefrontal cortex,
hippocampus, and thalamus. Mutant DISC1 may contribute to schizophrenia
susceptibility by altering neuronal architecture and migration. DISC1 single nucleotide
polymorphisms have been shown to be connected with sustained attention and working
memory deficits in schizophrenic families (Olgiati et al., 2009).
DTNBP1
Dysbindin is an evolutionarily conserved gene. An evolutionarily conserved gene
or protein has remained essentially unchanged throughout evolution. Conservation of the
gene indicates that it is unique and essential: there is not an extra copy of that gene and
changes in such a gene are likely to be lethal. Significant dysbindin reductions have been
found at presynaptic levels in glutamatergic afferents of the several brain regions such as
the hippocampus in schizophrenic brains. Sequence variations in DNTBP1 determine
reductions in dysbindin messenger RNA levels in the prefrontal cortex in schizophrenics
and mediate the risk of schizophrenia by lowering dysbindin expression. In samples of
schizophrenics, carriers of the DNTBP1 have been associated to early visual processing
deficits and a significantly lower spatial working memory performance. Genetic variation
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of DNTBP1 within carriers has also been shown to influence general cognitive ability
(Olgiati et al., 2009).
GRM3
A large body of evidence supports the involvement of the glutamate system (a
fast-signaling system that is very important for information processing in neuronal
networks of the neocortex and hippocampus in particular. Glutamate is also very much
involved in the process of long-term potentiation, which is a neuronal model of memory)
in schizophrenia (Olgiati et al., 2009). For example, glutamatergic NMDA receptor
antagonists (often drugs used to induce and maintain anesthesia) can cause psychotic
symptoms in healthy people and exacerbate psychosis in schizophrenics. GRM3 is a
metabotropic glutamate receptor modulating synaptic glutamate, and it has also emerged
as a promising candidate gene for the onset of schizophrenia. Variations in the gene
mediate glutamate release in the prefrontal cortex and aid cognitive functioning in
psychotic patients (Olgiati et al., 2009).
Epigenetics
Epigenetics was born out of the terms “genetics” and “epigenesis”--referring to
the study of causal relationships between genes and their phenotypic effects, but more
recently associated with the changes in gene activity independent of the DNA sequence
(Petronis, Paterson, & Kennedy, 1999). Often these modifications are a direct result of
environmental influences: obstetric complications, viral infections, stressful life events,
and substance abuse. It has been very clearly established that this gene-environment
interplay is critical for the onset of psychosis.
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The fundamental difference between epigenetic systems and DNA sequencebased heredity factors lies in the ability of epigenetic systems to change rapidly in
comparison to DNA sequence-based heredity. Epigenetic factors may only exhibit partial
stability when transmitted from parent to daughter cells, while DNA sequence
demonstrates nearly complete inheritance (Petronis, Paterson, & Kennedy, 1999). For
example, DNA methylation patterns undergo major reorganization during gametogenesis,
development, and aging. Numerous cellular functions are controlled and mediated by
DNA methylation: the regulation of gene activity, genomic imprinting, and genetic
recombination. In mammals, DNA methylation patterns are subjected to major changes
due to environmental influences. Therefore, epigenetic mechanisms such as methylation
have the potential to cause subtle changes in brain development such as those observed in
schizophrenia (Petronis, Paterson, & Kennedy, 1999).
Neurotransmitter Theories
Neurochemical theories for schizophrenia have been prominent for quite some
time. Many of these theories evolved in response to observed effects of antipsychotics,
antidepressants, or psychotomimetics such as amphetamines, and can now be tested by
examining gene, RNA, and protein expression (Torrey et al., 2005). Although
schizophrenia was once seen as a disease affecting only a few key brain regions and
regionally discrete neurotransmitter systems such as dopamine, more recent findings
implicate widespread cortical and subcortical dysfunction (Javitt, 2010). While originally
thought to be independent of one another, it is now evident that these neurotransmitter
systems affect each other and are very much interdependent.
GABA
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A 2005 study done by Torrey et al. sought to confirm neurochemical markers in
schizophrenia. To conduct the study, Torrey and his team examined post-mortem brains,
looking for abnormalities in neurochemical markers. They found that twenty-three
neurochemical markers (23% of the total) were significantly abnormal in one or more
brain region. As a percentage of the total markers included in this study, the
developmental/synaptic (10/22 were found to be abnormal) and GABA (3/7 were found
to be abnormal) neurochemical systems had the most abnormalities.
The major finding to emerge from this study is the involvement of the GABA
system in the pathophysiology of schizophrenia (Torrey et al., 2005). GABA is the major
inhibitory neurotransmitter in mammalian brains and used by approximately 40% of all
neurons. Abnormalities in the GABA system in schizophrenia have been identified in the
GABA transporter, receptors, and in neuron density. The GABAergic system is also
thought to interact with the dopamine system and with the excitatory glutamatergic
system (Torrey et al., 2005).
Perhaps the most interesting finding is that almost all abnormalities represent
decreased expression compared with the unaffected control subjects. The direction of
such findings suggests a widespread failure of gene expression in the major psychiatric
disorders, leading to malfunctioning neurotransmitter systems, as evidenced by these
findings on GABA (Torrey et al., 2005).
Dopamine
Dopamine is a neurotransmitter produced in the substantia nigra, a portion of the
midbrain that has an important role in reward, addiction, and movement. Dopamine
alterations are related to schizophrenia. The “original dopamine hypothesis” states that
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hyperactive dopamine transmission results in schizophrenic symptoms. The positive
symptoms of schizophrenia include hallucinations and delusions as a result of increased
subcortical release of dopamine, which augments D2 receptor activation, resulting in
these over percieved sensations (Brisch et al., 2014).
There is ongoing discussion regarding the involvement of D1 and D2 receptors in
cognition in schizophrenia patients. Cognitive discrepancies and working memory
deficits in the prefrontal cortex are associated with an increase in dopamine and D1
receptors in the prefrontal cortex in schizophrenia patients (Brisch et al., 2014).
Glutamate
While dopaminergic models of schizophrenia take only positive symptoms into
account, glutamatergic models help to account for the negative and cognitive symptoms
(Javitt, 2010). The first alternative to the dopamine hypothesis was first proposed in the
early 1990s, based on the observation that ketamine-like compounds induced unique
behavioral effects by blocking neurotransmission at N-methyl-D-aspartate (NMDA)-type
glutamate receptors. The ability of these compounds to imitate key symptoms in
schizophrenia by blocking NMDA receptors led to the concept that symptoms in
schizophrenia may reflect underlying dysfunction or dysregulation of NMDA receptormediated neurotransmission (Javitt, 2010).
Interestingly, when patients with schizophrenia are exposed to ketamine, they also
show increases in positive symptoms, as well as negative symptoms, suggesting that
NMDA antagonists affect a brain system that is already vulnerable in schizophrenia. As
opposed to ketamine, administration of dopamine agonists such as amphetamine does not
reproduce the pattern of deficit observed in schizophrenia. New treatment approaches
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based upon glutamatergic approaches are only now reaching the clinical stages and will
serve to further elucidate and refine these models over upcoming years (Javitt, 2010).
Neuropathological Theories
Finding the neuropathology of schizophrenia has been one of the major, failed
quests of biological psychiatry for over 100 years. In fact, one American neurologist
called the disease the “graveyard of neuropathologies” (Harrison, 2008). Two early
researchers, Alzheimer and Southard, were the first to describe any neuropathological
changes in the brain’s cortex in the late nineteenth century. They found volume loss of
the cortical gray matter, different vulnerabilities of cortical neurons toward injury, low
glial to neuron ratios, and abnormalities in the position of neurons within the cortical
layers. Interestingly, many of these original findings are still being investigated (Heckers,
1997). Even so, a major challenge of neuropathological studies that examine postmortem
tissue is controlling for the tissue changes after death, particularly brain shrinkage. This
tissue shrinkage creates issues in the two most-studied parameters, brain volume and cell
density (Heckers, 1997).
More modern neuropathological techniques have been made possible thanks to
brain imaging. MRIs now show clearly that there are structural brain differences in living
patients with schizophrenia. Neuropathological alterations are present in patients
experiencing their first episode, and some also in at-risk subjects, indicating that there is
pathology that cannot be explained as simply an artifact of the chronic illness itself or
antipsychotic medication (Harrison, 2008). There are two important findings from
neuropathological studies done thus far. First is that the neuropathology of schizophrenia
is not neurodegenerative, as there are no structures that indicate such findings. Next, is
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that although early studies have often made the claim, there is no gliosis (proliferation of
the supporting cells in the brain) in schizophrenia. Gliosis is a sign of inflammation,
injury, etc.; therefore, the lack of gliosis is often taken as a sign that the disorder is likely
to be neurodevelopmental in origin (Harrison, 2008).
There are many studies that have attempted to examine the neuropathology of
schizophrenia. Unfortunately, only one theme has emerged from them: the inability to
replicate. Nevertheless, there are a few promising studies that have found an increased
packing density of neurons within the cerebral cortex (Harrison, 2008). This finding has
contributed to the understanding of schizophrenia as a disease of neural connections.
Many studies in neuropathology of schizophrenia have found a decreased size of
pyramidal neurons. The size of a neuron is related to the volume of axons and dendrites
that it can support--therefore its synaptic activity. Therefore, schizophrenic neurons are
making fewer or less active connections within the brain (Harrison, 2008). The thalamus,
a collection of nuclei that serve as the primary relay station to the cerebral cortex is also
an area of particular interest, and it has been found to be smaller and contain less neurons
in several schizophrenia studies. Conclusively, there is some evidence for a
neuropathology of schizophrenia; however, the details of these changes remain elusive.
Developmental Theories
There are several lines of evidence that indicate early brain development in the
onset of schizophrenia. This evidence is consistent with the view that the
neurodevelopment of schizophrenia is partly present from birth and may therefore
explain motor language, and social affective delays and other deficits in neurocognitive
functioning in children who later develop schizophrenia (Cannon et al., 2003).
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The timing of certain environmental factors linked to increased risk for
schizophrenia does provide perhaps the most direct evidence to date that early
neurodevelopmental disturbances are involved. For example, prenatal complications like
hypoxia (deficiency in amount of oxygen in tissues) appears to be a risk factor in about
30-40% of pregnancy complications. Therefore, complications that are associated with
fetal hypoxia are of particular interest, as they represent a very plausible mechanism for
explaining many issues that are found in adult neuropathology (Cannon et al., 2003).
In addition to issues that arise because of hypoxia, there is now sufficient
evidence from both animal and human models that have implicated influenza during
gestation specifically as a concern for the increased risk of several psychological
disorders, including schizophrenia. In fact, one study that examined schizophrenics born
between 1959 and 1966 found that the presence of maternal antibodies for influenza
during pregnancy created a four to seven fold increase in risk for psychiatric diseases
(Short et al., 2010). Unsurprisingly, concern arose from this study and experiments
replicated on animal models followed. Researchers soon found that decreased cortical
thickness and smaller hippocampal volumes in the brains of rodents occurred when they
were exposed to the influenza virus (Short et al., 2010).
Microarray (method to detect DNA or RNA that can potentially be used to create
proteins) analysis from the rodent models have helped to indicate that these
neuropathological differences might be caused by both and up- and downregulation of
genes for the structural proteins such as reelin--a protein known for its importance in
neural migration and several other important neural processes. The study conducted by
Short et al. sought to determine whether infection in late pregnancy would result in

51

persistent brain changes that are large enough to be viewed with neuroimaging techniques
(MRIs) in rhesus monkeys. Rhesus monkeys were chosen as a model to investigate given
the similarities between their placental functioning in relation to humans.
The results from this study indicated that even in the absences of an effect on
gestation length and birth weight (controlling for the rodent models), prenatal infection
can significantly reduce brain size in the young monkeys (Short et al., 2010). Based on
these results, the researchers inferred that these alterations would persist, as reduced
volumes are evident at a stage in the monkeys that are equivalent to late-childhood in
humans. The nature and extent of the brain volume reductions seen in the monkey bore
the most common with the structural abnormalities frequently found in schizophrenics,
indicating that exposure to influenza virus in gestation can predispose one to
schizophrenia (Short et al., 2010).
Infectious Theories
There are several aspects of psychotic disorders that suggest a possible infectious
origin. One is the observation that people who experience microbial diseases often
express the symptoms of schizophrenia and other psychological disorders such as bipolar
disorder and depression (Torrey & Yoken, 2008). There is a long list of infectious agents
that have been suspected culprits, including: the bacteria that causes syphilis, the bacteria
known for causing Lyme disease, the herpes virus, measles, mumps, rubella, polio,
retroviruses such as HIV, and the protozoan T. gondii. Nevertheless, when one considers
epidemiological aspects many of these candidates become very unlikely suspects. For
example, schizophrenia like symptoms have been described for over 200 years, but HIV
has only recently infected human populations, ruling it out as a probable cause (Torrey &
Yoken, 2008).
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One particularly interesting epidemiological aspect of schizophrenia is that there
has been a seasonal birth predominance in the winter and spring months. Interestingly,
over 200 studies have demonstrated this finding, and it is actually the most consistently
replicated findings in all of schizophrenia research. If an infectious agent is responsible
for the seasonality, it would be one that occurs throughout the year but that has a modest
seasonal predominance. The infectious agent would also be one that does not vary in its
occurrence from year to year--the flu virus, perhaps? (Torrey & Yoken, 2008). Another
epidemiological factor that must be considered is that being born and raised in urban
environments compared to rural environments can sometimes double the risk of later
being diagnosed with schizophrenia. A dose-response relationship has been proposed in
that the longer one lives in an urban environment, the higher degree of risk they adopt
(Torrey & Yoken, 2008). The exact mechanism is, of course, not fully understood;
however, the greater population densities found in cities is often associated with the
transmission of a wide array of microbes.
Toxoplasma
T. gondii or toxoplasma is a protozoan whose definitive hosts are felines,
particularly the domestic cat. Toxoplasma can only complete the sexual part of its
lifecycle within the feline host. Toxoplasma oocysts (a cyst containing a zygote formed
by a parasitic protozoan) are excreted through feline feces. The oocysts may then be
released into the air to infect humans who might be changing the litter box, gardening,
etc. Cat feces are also often found in the ground of or in animal feed troughs of barns,
domestic animals then eat it, the oocysts are produced in their muscles, thus later
affecting humans who might consume undercooked meat (Torrey & Yoken, 2008). Feline
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feces can potentially contaminate water supply as well. Toxoplasma is found world wide
as has been found to affect anywhere from 10-80% of the adult population, with about
25% of adults projected to be infected in the United States.
Toxoplasma is a known neurotrophic--infecting both neurons and glia. Until
recently there was little to no understanding of the molecular biology behind
toxoplasma’s mechanisms of infection. However, protozoan genomes have since been
sequenced and an increased understanding of toxoplasma infections has followed.
Researchers have recently discovered that toxoplasma’s protein kinases (proteins
involved in cellular signaling) alter signal transductions in infected hosts, compromising
immune function (Torrey & Yoken, 2008).
One might be wondering: why would a microbial agent lead to the altered
behavior that is present in schizophrenia? To answer simply, toxoplasma alters the host
behavior in order to enhance its own survival and reproductive success. Mechanistically,
felines are the natural hosts for toxoplasma; therefore, if toxoplasma enters a cat, it can
fulfill its entire lifecycle. However, if toxoplasma infects another animal, toxoplasma
faces a problem, as it cannot complete its lifecycle in any other animals besides felines.
Nevertheless, if toxoplasma can get its host to be eaten by a feline, it will be able to
complete its lifecycle within its feline host (Torrey & Yoken, 2008).
All felines are carnivores; therefore, the possibility that another animal will be
eaten by them is conceivable, especially if said animal is a small rodent. Recent research
has uncovered that toxoplasma is successful at altering small rodent behavior, ensuring
that these small rodents lose their inherent fear of cats. Therefore, this adaptation of the
parasite ensures that the hosts are consuming more rodents infected by toxoplasma,
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allowing toxoplasma to infect its proper host and complete its lifecycle (Torrey & Yoken,
2008).
You might be thinking: humans are not normally consumed by domestic cats.
This means that toxoplasma effects seem to be vestigial in humans. However, two studies
have demonstrated that young adults that are infected by toxoplasma have an increased
rate of automobile accidents, a behavior very much associated with risk (Torrey &
Yoken, 2008). True to most research on schizophrenia, the exact mechanisms as to how
toxoplasma creates such psychosis are currently unknown. However, researchers believe
that one possibility is the direct effect of the organism on neurons and glial cells cited
earlier. As of yet, it is known that toxoplasma may affect signal transduction pathways
and that it also encodes proteins that might interfere with the synthesis of dopamine in
human hosts, a known cause of schizophrenia symptoms (Torrey & Yoken, 2008).
Each respected theory of causation has its strengths and weaknesses. While I have
presented each separately, for organizational purposes. They should be taken together to
create a holistic model of causation. In addition, every theory may not apply to one
individual. For example, there are plenty of schizophrenics that are not infected with
toxoplasma. When taking all of the respected theories into account, one wonders how
scientists could have even dreamed to believe that a single gene was the culprit of the
illness.
An Enigmatic Legacy: Evolutionary Theories of the Schizophrenia
A textbook on evolutionary psychology says that the evolutionary approach to
mental illness is characterized by a variety of attempts to classify and explain the
disorders in terms of the fundamental architecture of the brain as laid down by natural
and sexual selection. The textbook goes on to summarize that since it’s inception,
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evolutionary psychology has stressed that the cognitive and emotional systems we
possess, were designed to cope with problems that are much different from those present
in the modern world. According to Darwin’s Origin of Species, the process of natural
selection preserves genetic variants associated with survival and reproductive advantage,
while genetic variants associated with low fitness are eliminated from the gene pool.
Therefore, why has natural selection not eliminated genes that might predispose one to
psychiatric disorders like schizophrenia? This question has been addressed by many and
is commonly known as the evolutionary paradox of psychiatric disorders. In relation to
schizophrenia, those affected show lower reproductive success and suffer from greater
mortality from both natural and unnatural causes like suicide than the greater population.
Therefore, why has the disorder remained prevalent, consistently affecting about 1% of
the world’s population (van Dongen & Boomsma, 2013)? As I previously mentioned, it
was this question that gave me the inspiration to write this thesis, and I found its
explanations just, if not more, fascinating than the question posed. Next, I will review
some of the theories that have been suggested, taken from a recent review by van Dongen
and Boomsma, The Evolutionary Paradox and the Missing Heritability of Schizophrenia.
First the researchers cite a study entitled Schizotypy, Creativity, and Mating
Success in Humans by Daniel Nettle and Helen Clegg. This study first notes that many
prior studies have found a relationship between those active in the creative arts and
schizotypal traits. The authors pose, why would artistic creativity contribute to
reproductive success? They note that some researchers have argued that human artistic
qualities have origins in the costly displays of quality. Therefore, the function of such
qualities is similar to that of the quintessential peacock’s tail (Nettle & Clegg, 2005).

56

Nettle and Clegg’s study examined the relationship between schizotypy and mating
success in a large sample of British adults.
The results of the study showed a significant positive relationship between
unusual experiences and mating success. Nettle and Clegg hypothesize that in the case of
unusual experiences, the relationship is mediated by creative activity; those high in
unusual experiences produce poetry or art more seriously, and this in turn increases
mating success. They found that increasing this trait lead directly to an increased number
of sexual partners. Therefore, these results are consistent with the view that schizotypal
traits are maintained in the human population at significant levels because the negative
effects in terms of psychosis are offset by enhanced mating success. The study notes that
first degree relatives of schizophrenics are often “strikingly creative individuals.”
Therefore, this theory asserts that mating success given from schizotypy traits like
creativeness could be the reason that schizophrenia has persisted. Although I am a second
degree relative to my schizophrenic Aunt Linda, I would dare say that I have been given
my fair share of creative traits, and I can attest that they did not come from my mother or
father. Nevertheless, I am still waiting for them to land me a mate… Therefore, van
Dongen and Boomsma stress that this explanation is not enough to explain the
persistence of the genes associated with schizophrenia over the course of evolutionary
history.
Still, others have suggested that schizophrenia may have arisen as an unfavorable
but inevitable byproduct of the evolution of the human brain. Therefore, schizophrenia
would represent an extreme end of the normal variation of cognition (van Dongen &
Boomsma, 2013). It has been proposed that schizophrenia could be regarded as an outlier
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on a normal continuum of social behavior and possibly even the toll that humans pay for
the benefit that social skills have given. Another researcher proposed the link between
schizophrenia, language dysfunction, and cerebral flexibility to hypothesize that
schizophrenia reflects the extreme end of variation underlying language capacity. In other
words, schizophrenia is the price we pay for being able to communicate. According to
this theory, positive selection on cerebral flexibility was the associated variation in
psychological functioning, resulting in schizophrenia at the extreme end of the spectrum
(van Dongen & Boomsma, 2013).
Another important aspect of human brain evolution is the role of neural
connections. According to the researcher Randall, the random establishment of novel
pathways within the brain throughout its development can produce advantageous
connections. However, in what some would call biological trial and error, that brain has
mistakenly given rise to a range of behavioral variants like schizophrenia. Nonetheless,
one must reason that if schizophrenia exists as a byproduct of extreme traits, the question
as to why genetic variants that cause these extremes are maintained still exists (van
Dongen & Boomsma, 2013).
Balancing selection refers to a situation where multiple alleles may be maintained
in the gene pool if the genotypes are under different selection pressures. One example of
balancing selection is presented by antagonistic pleiotropy, where the effect of the gene is
associated with both advantageous traits and disadvantageous traits within the same
person, making the gene neutral with respect to natural selection (van Dongen &
Boomsma, 2013). Could this be the case in schizophrenia?
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Another example of balancing selection is presented by polymorphisms, a topic
already discussed in the genetic section. It has been proposed that genetic variants that
predispose to fitness-reducing psychiatric disorders in homozygotes are maintained in the
population because they are associated with a fitness-increasing trait in a number of
carriers. This effect is evidenced by the COMT gene polymorphism. The valine allele is
associated with lower dopamine levels, and the methionine allele is associated with
higher dopamine levels. Some researchers believe that schizophrenia risk alleles could be
maintained in the population because they provide beneficial cognitive or somatic traits
in unaffected carriers of these alleles. For example, a met/val carrier might experience
more reward because of an increase in dopamine. While schizophrenia may be present in
homozygous (met/met) individuals. Heterozygous (met/val) carriers might experience
superior social skills, creativity, and cognition. Nevertheless, most studies indicate that
the fertility of relatives is not sufficient enough to outweigh the immense reproductive
cost that schizophrenia inflicts on a population (van Dongen & Boomsma, 2013).
Another hypothesis along the same lines is called cliff-edged fitness. It refers to
the increase in fitness associated with increased expression of a trait up to a certain point,
above this point and increased expression is associated with a sharp drop in fitness (van
Dongen & Boomsma, 2013). Are schizophrenia traits beneficial until a certain point
where the illness sets in? The cliff-edged theory is not perfect, as it still does not make
clear why natural selection would maintain harmful alleles that have the potential to lead
to schizophrenia.
From an evolutionary perspective, all phenotypes can be regarded as
compromises. Evolution does not strive for perfection. Rather, it drives traits towards an

59

optimum level where fitness and trade-offs are balanced. Therefore, the question arises:
can schizophrenia be eliminated by natural selection without also losing valuable
cognitive traits along with it? (van Dongen & Boomsma, 2013).
Another hypothesis proposed is called the triune brain concept. It is a model in
which the human brain contains the evolutionary remnants of three ancestral brains: the
reptilian brain (upper brain stem), the paleomammalian brain (limbic area), and the
neomammalian brain (cortical region). According to this model, each successive brain
area that was introduced incorporates and modifies previous functions. The researcher
Millar proposed that the introduction of each successive brain feature may have come
with difficulties in connecting pre-existing areas to novel parts. Millar hypothesized that
schizophrenia may reflect a failure of integration between different parts. Nevertheless,
the benefits of having a more complex brain have allowed for novel functions such as
language, thus outweighing the disadvantage of a design prone to maladaptive error (van
Dongen & Boomsma, 2013). But the question remains, why do errors in brain
development only lead to problems in some individuals but not everyone? (van Dongen
& Boomsma, 2013).
Schizophrenia has been suggested to represent an adaptively programmed
phenotype that is induced by environmental adversity. Many organisms express variable
morphologies in response to variable environmental conditions encountered during
development, many of which are thought to represent alternative survival or reproductive
strategies (van Dongen & Boomsma, 2013). The phenotypic plasticity hypothesis states
that exposure to adverse environmental cues during early development may induce
alterations in the expression of genes, resulting in a phenotype that is better suited for a
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stressful or deprived environment, some of the core symptoms of schizophrenia that
predict social and vocational disabilities in modern times, such as the inability to calm
instinctual drives, ignore arousing stimuli, and inhibit transient desires may represent a
“defensive, vigilance-based behavioral strategy that alerts the organism to salient,
potentially informative stimuli and permits it to be more impulsive and vigilant” (van
Dongen & Boomsma, 2013). Therefore, schizophrenia must be related to physiological
and behavioral characteristics that created a fitness advantage in our ancient ancestral
environment under conditions of nutritional scarcity and severe environmental stress.
What's more, schizophrenia is linked to stress exposure during development.
The model of genetically inherited epigenetic variation may explain how the
persistence of disadvantageous traits like schizophrenia may be stimulated by the
pressures of variable environments, and at the same time have a heritable basis (van
Dongen & Boomsma, 2013).
For example, sexual conflict arises when the two sexes of a species have
conflicting optimal reproductive strategies, leading to an evolutionary arms race between
males and females. In mammals, the mother is predominantly responsible for providing
resources to offspring pre- and perinatally. As a result, the fitness of maternally derived
alleles favors smaller demand on maternal resources, anticipating the survival of future
offspring. Paternally derived alleles are associated with high fitness if offspring exploit as
many resources from the mother as possible (van Dongen & Boomsma, 2013).
Imprinted genes or genes whose expression is determined by the parent that
contributed them, the expression pattern of an allele depends on its parent of origin.
Typically, one allele is expressed, while the other is transcriptionally silent. The kinship
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theory of imprinting states that the evolution of imprinted gene expression originates
from the conflict of interests between maternally and paternally derived alleles (van
Dongen & Boomsma, 2013). Paternally derived alleles favor higher growth rates of
offspring and greater demands on maternal resources than maternally derived alleles.
Therefore, growth promoting loci are often maternally silenced through imprinting,
whereas loci that suppress growth are often paternally silenced (van Dongen &
Boomsma, 2013).
Researchers Badcock and Crespi suggest that the “genetic war” at imprinted
genes for brain development may give rise to mental disorders if expression is pushed too
far towards the benefit of one parental alleles. Paternally biased expression of genes
involved in brain development may give rise to a self-oriented child that is highly
demanding to its mother-- extreme cases of this behavior are cited as autism. Badock and
Crespi hypothesized that small deviations in imprinted gene expression towards a
maternal bias may lead to offspring that are energetically “cheaper” and easier
behaviorally to mothers, less demanding and better capable of interpreting and
understanding the mental states of others. As such, large maternally biased deviations
may lead to psychosis. Badock and Crespi also suggest that several characteristics of
autism and psychosis may be regarded as opposites in the context of parental demand.
Autism spectrum conditions are characterized by deficits in theory of mind skills,
whereas psychotic spectrum conditions involve the opposite: “hyper mentalism.” For
example, autistics are characterized by a defective detection of gaze and inability to
appreciate what goes on in groups, while individuals with schizophrenia may experience
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paranoid delusions of conspiracies and being watched by others (van Dongen &
Boomsma, 2013).
Therefore, fluctuations in imprinted gene expression that result from the ongoing
conflict between reproductive strategies of males and females may contribute to the
persistence of fitness decreasing conditions such as schizophrenia. Because epigenetic
mechanisms that regulate imprinting can be influenced by genetic variation, this theory is
compatible with the persistence of heritable variation (van Dongen & Boomsma, 2013).
Furthermore, the genomic conflicts that arise can cause natural selection to drive
phenotypes away from their optimum values, resulting in a maladaptive, but selectively
favored evolutionary trajectory. Therefore, mental disorders that occur at high
frequencies despite reducing individual fitness, such as schizophrenia, may be related to
effects of imprinted gene expression in the brain (van Dongen & Boomsma, 2013). While
many of the hypotheses presented are both interesting and logical, most fail to account
for the genetic component of natural selection. Therefore, the hypothesis of imprinted
genes is the strongest presented, as it gives an explanation for the heritability of
schizophrenia.
The Battle Behind the Forehead: Treatment Strategies
From the vast array of theories that attempt to explain why schizophrenia exists
and persists, I hope that I have left little doubt that the disease is complicated. Therefore,
it should come as no surprise that treating the disease is, well, complicated. Nevertheless,
recovery is no longer viewed as impossible, but it is now expected. In 2004 a major
attempt at creating a working definition for what recovery from schizophrenia looks like
happened at conference held by the Center for Mental Health Services Administration, a
division of the US Department of Health and Human Services. While at the conference
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family members, administrators, mental health professionals, and recovering
schizophrenics agreed on a national consensus statement on mental health recovery:
“Mental health recovery is a journey of healing and transformation enabling a person
with a mental health problem to live a meaningful life in a community of his or her
choice while striving to achieve his or her full potential.” Participants at the conference
also agreed on the “The 10 Fundamental Components of Recovery.” They are as follows:
self direction, the recovery process must be self-directed by the individual who designs
his or her own life goals; individualized, there are multiple pathways to recovery based
on an individual's own unique strengths and weaknesses; empowerment, individuals have
the ability to speak for themselves about their needs and desires; holistic, recovery
encompasses an individual’s whole life--mind, body, spirit, and community; nonlinear,
recovery is not a step-by-step process but one that is based on continual growth with
some setbacks along the way; strength based, recovery focuses on valuing and building
on the multiple capacities of an individual; peer support, sharing of knowledge and skills;
respect, trying to eliminate discrimination and stigma; responsibility, taking steps towards
one’s own goals; and finally hope, ensuring a message of a better future (Frese et al.,
2009). Today’s recovery model is more effective than ever before. I will go over a few of
the aspects of this model in detail, focusing primarily on antipsychotics and some
varieties of psychosocial therapies. Finally, I will address the idea of early intervention,
and how this model strives to bring better treatment results.
Antipsychotics
Upon diagnosis with schizophrenia, one will undoubtedly begin a routine of
antipsychotics. Antipsychotics treat the psychosis of schizophrenia--delusions,
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hallucinations, and disordered thought. Although these drugs are effective, they are
undoubtedly controversial due to their often debilitating side effects. Elyn Saks loathed
taking antipsychotics because of their side effects, she complains in The Center Cannot
Hold, “Soaked in antipsychotic medication, with the psychosis actually clearing, I
became profoundly depressed, and felt the brief flash of energy and focus leak right out
of me. Suddenly, I couldn’t follow the simplest sitcom on the unit TV, or decipher the
lines in a book I’d been reading days before… It’s not that I wasn’t trying--I just couldn’t
function” (Saks, 2007). While antipsychotics available today are very helpful, they are far
from perfect. There is still a long way to go in the way of research.
The first generation of antipsychotics was discovered in the 1950s by accident as
a surgical anesthetic in France. Forty years later the second generation of antipsychotics
became available. The first generation of antipsychotics are now referred to as typical
antipsychotics. They work by antagonising dopamine receptors and are known for their
side effects that cause the sensation that was just described by Elyn Saks. The D2
receptor is often referred to as the antipsychotic receptor. The second generation of
antipsychotics gained populace in the 1990s for their novel addition of serotonin
antagonism (Fitzpatrick, 2012). Antagonism of serotonin regulates dopamine release in
the striatal, pituitary, and neocortical regions of the brain. This mechanism
counterbalances the depletion of dopamine caused by typical antipsychotics. As
antipsychotics go on and off the D2 receptor rapidly, DA is allowed to bind and release
from the same receptors. This dynamic process seems to explain how atypicals are
effective in producing an antipsychotic effect without the severe side effects of typical
antipsychotics (Fitzpatrick 2012). Dr. Ted Bitner, an assistant professor of psychology at
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DePauw University and practicing clinical psychologist, began practicing in 1991.
Therefore, he has seen first hand the difference in treatment between typical and atypical
antipsychotics, “The first generation didn’t allow any kind of life outside of the home or
the hospital. Remember that at the end of the 1980s, we were just beginning to adjust to
no psychiatric hospitals, so many of these people became homeless. But when the 2nd
generation came along, people were given less restricted environments” (personal
communication, April 7, 2016).
Some popular antipsychotics available include: aripiprazole, olanzapine,
quetiapine, ziprasidone, and clozapine. Olanzapine, whose brand name is Zyprexa, was
created by Eli Lilly, and was the first antipsychotic known for its side effect of serious
weight gain. While these drugs might be effective for some, clozapine is considered the
gold standard in efficiency for all schizophrenia patients--especially those at risk of
suicide. The drug was discovered in the 1960s but continues to offer hope to treatment
resistant individuals today. It has a low propensity for extrapyramidal side effects, even at
high doses, but there are many life threatening side effects that disable it from being the
first line of treatment. It is prescribed only when other antipsychotics fail.
Lori Schiller was one of these infamous treatment resistant patients. She recalls
her experience with medications in The Quiet Room:
“I took pills for psychotic symptoms, pills for mood swings, and pills for anxiety.
Because nothing had ever really given me long-term relief, the doctors were
constantly trying me on something new. I went from one antipsychotic medication
to another. Navane. Stelazine. Mellaril. Moban. Haldol. Nothing. Nothing.
Nothing” (Schiller, 1996).
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She recalls the nature of the side effects as well,
“I knew these medications mainly by their side effects. Some antipsychotic
medications made me drowsy. Some blurred my vision. When I took Thorazine I
felt like a zombie. My face looked like the frozen mask of someone who had been
dead for weeks. I shuffled down the halls and my mind was a shadowy cloud...It
gave me an appetite like a lumberjack and caused me to gain weight like crazy.
My mouth was so dry that my lips would get stuck on my gums. Haldol didn’t
help the symptoms, and the side effects were horrible and scary” (Schiller, 1996).
Thankfully, Lori got the relief she so deserved when she signed up for one of clozapine’s
first clinical trials in the United States. She retells her initial experience with clozapine,
“Gradually, subtly, changes began creeping up on me. People began remarking
on my changed demeanor. I was less impulsive, they said, and more thoughtful. I
was looking brighter, more alive, they said. My parents said they saw beginnings
of the sparkle back in my eyes again. The most striking thing I felt was a new
sense of calm. For the first time in years, I slept… And the Voices? The Voices
were growing softer… It was happening. I was being set free. I had prayed to find
some peace, and my prayers were finally being answered” (Schiller, 1996).
Clozapine
The story behind clozapine, the gold standard, is a blend of medical
misconceptions, public health scares, and accusations of company profiteering (Crilly,
2007). In 1953 the first clinical trials for the first antipsychotic drug had made their way
to North America, and it was quickly approved by the FDA in 1954. The discovery of
chlorpromazine in America created a huge boom in pharmaceutical research that
ultimately led to the discovery of clozapine (Crilly, 2007).
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In 1958 a group of tricyclic compounds were synthesized as antidepressants in a
Swiss lab, one named clozapine was noticed to have similar properties to chlorpromazine
but researchers noted how it differed in the lab in two important ways: first, it did not
cause the loss of voluntary motion that was so common in chlorpromazine. Second, it
demonstrated a higher pain threshold in rats. Interestingly, it was the second quality of
the drug that led to further testing on humans. A number of clinical trials showed mixed
reviews of clozapine, but a German lab finally confirmed the drug’s antipsychotic
properties. The German trial also famously and foolishly noted that the drug did not have
any disabling neurological side effects. However, it was the extrapyramidal side effects
that made antipsychotics so novel in the 1950s. In fact, many believed the more severe
the extrapyramidal symptoms, the better the antipsychotic (Crilly, 2007). Therefore,
clozapine was not met with the same enthusiasm that chlorpromazine was. Nevertheless,
clinical trials continued in Europe, and the drug company Sandoz began to make plans to
bring clozapine to the United States.
Drug development in Europe is much different than it is in the United States
because of the role of the Food and Drug Administration. The FDA controls new drugs
coming into the market as well as ensuring product efficacy. The FDA’s role in the
development in a new drug begins when a pharmaceutical company seeks to test potential
therapeutic effects on humans. An “investigational new drug” application is submitted at
this stage. After this, the three phases of clinical trials can officially begin. Upon
completion of phase III, the company must submit a “new drug application” to the FDA
for approval. Once approved, the drug can at last be brought to market. In 1973, Sandoz
began this process in the United States for clozapine. By 1974, Phase II trials had begun
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on male volunteers in prisons. However, it was at this phase that the hypotension side
effect was discovered. Some of the men were quite literally crashing from the drug. The
researchers reasoned that the hypotension was due to high doses given too quickly. The
solution--a dosing regimen, start low and build to effective dosage levels (Crilly, 2007).
Momentum of getting clozapine to the US market slowed to a complete halt in
1975 when 18 patients in Finland on the drug developed severe blood disorders, and 9
lost their lives. Sixteen of these patients developed the now known side effect
agranulocytosis. Agranulocytosis suppresses the production of white blood cells in bone
marrow, leaving one vulnerable to infection (Crilly, 2007). Upon these deaths, several
European governments ordered clozapine to be removed from the market. When these
deaths were investigated, the researchers found that it was due to secondary infection due
to agranulocytosis. They reasoned that the agranulocytosis was not diagnosed early
enough so that clozapine could be withdrawn immediately. Following the Finnish
incidence, there was mandatory implementation to weekly screening white blood cell
counts for patients using clozapine (Crilly, 2007).
Unsurprisingly, the FDA in the United States was concerned about what had
happened in Finland. Consequently, stage III of the clinical trials soon proved to be the
most difficult hurdle to jump. To understand why, one must consider the political climate
of the early 1980s. The Reagan administration pushed for ideals of competition, free
enterprise, and greater involvement by the private sector in the healthcare field (Crilly,
2007). However, the appeal of clozapine was that it treated mental illness, a cohort that
was mostly reliant on Medicaid. It was also during this time that the FDA helped pass the
Drug Price Competition and Patent Term Restoration Act of 1984. These acts began to
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allows generic drugs to proceed to market with minimal delay--guaranteeing only a 5
year period of exclusivity for the brand name drug following FDA approval. This policy
gives pharmaceutical companies incentive to profit as much possible during those 5
years--forcing Sandoz to organize a plan to maximize its profits from clozapine in the US
market (Crilly, 2007).
In the 1980s state governments were looking at any possible way to decrease state
hospital stays for schizophrenic patients and create venues for less expensive treatment.
Sandoz knew that clozapine could play a truly pivotal role in this operation (Crilly,
2007). Therefore, the FDA was supportive during stage III trials for clozapine. However,
the FDA forced Sandoz to test subjects who had been failed by every other possible
treatment--clozapine was their last chance. The trial compared clozapine’s effectiveness
to chlorpromazine. Although Sandoz was given the toughest crowd to work with,
clozapine showed a clear superiority. It was approved by the FDA, despite lingering
worries of agranulocytosis.
Clozaril, clozapine’s brand name, entered the US market in 1990. The cost was
stifling--almost $9,000 per patient. Many families had to pay for the medication out of
pocket, as neither Medicaid nor private insurance was willing to pay for the drug and the
weekly tests for agranulocytosis (Crilly, 2007). Naturally, the outcry against the
outrageous cost came loudly and quickly. By December of 1990, 29 states had brought
the issue to federal court. A hearing convened in March of 1991 that sought to address
Medicaid’s inability to pay for the drug. Several physicians spoke at the hearing, making
a case that the drug could be marketed at just $200 per year, per patient. The final ruling
came in May of 1991, and both Sandoz and the states were found at fault for barriers to
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access to Clozaril (Crilly, 2007). State Medicaid programs were thereafter mandated to
pay for the drug and the required blood tests.
Throughout the 1990s Clozaril was described as ‘new’--atypical even (Crilly,
2007). Therefore, it created a second scramble by drug companies to develop their own
atypical antipsychotics--Zyprexa by Eli Lilly, Geodon by Pfizer, and Risperdal by
Janssen to name a few. Nevertheless, clozapine remains the most effective antipsychotic
on the market, particularly for treatment resistant cases. However, the fact that a nearly
60 year old drug remains to be the gold standard is troubling. There is little excuse for
such lack of development, especially when so many face unrelenting psychosis coupled
with horrific side effects of the antipsychotics available today.
Despite its demonstrated efficacy in psychosis and the expanding indications for
its use, widespread use of clozapine has been limited by the potential for adverse effects.
Adverse effects limit the rate at which the dose can be increased, as well as the maximum
dose that can be tolerated by some patients. For many patients, clozapine is their best
hope for successful treatment of a disabling mental illness. However, full benefit of the
drug can only be achieved if the adverse effects can be controlled (Young, 1998). Below
the adverse side effects of clozapine that must accounted for are recounted by Young.
Some of them are found only in clozapine but several are common to most
antipsychotics. They include: agranulocytosis, seizures, sedation, tachycardia, orthostatic
hypotension, weight gain, and gastrointestinal problems, urinary incontinence, and
akathisia.
Agranulocytosis is defined by low granulocyte count. The risk of agranulocytosis
is highest in the first three months of clozapine treatment, and 95% of the cases occur
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within the first 6 months. Agranulocytosis predisposes patients to neutropenic sepsis and
has a mortality rate of 3 to 4%. Mortality rate can be significantly decreased if
agranulocytosis is discovered before signs of infection and if clozapine is immediately
discontinued. The pathophysiological mechanism is uncertain, but there is evidence of an
immunological basis. Therefore, treatment with clozapine requires a weekly white blood
cell count.
Seizures tend to occur during the upward titration phase of treatment or at
exceedingly high doses. In Europe, lower total doses have generally been used with equal
efficacy and fewer seizures. The risk of seizures ranges from 1 to 3% at low doses and
up to 5% at high doses.
Sedation is the most frequent reported adverse effect of clozapine, occurring in
approximately 39% of patients. It appears early in treatment and patients gradually
develop tolerance, usually within 4 to 6 weeks of treatment.
Tachycardia or rapid heart beat from clozapine occurs in approximately 25% of
patients. Tolerance generally develops within 4 to 6 weeks but may limit the rate at which
the dose can be raised.
About 9% of patients receiving clozapine experience orthostatic hypotension. It
usually occurs at the initiation of treatment or with dosage increases, and patients
gradually develop tolerance, usually within 4 to 6 weeks of treatment. Patients with
orthostatic hypotension secondary to clozapine may describe dizziness or lightheadedness
and are prone to syncope. It can be monitored by taking sitting and standing blood
pressures regularly when therapy is initiated or when dosage increases.
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Weight gain is a frequent side effect of neuroleptic treatment. Recent studies have
suggested that the weight gain associated with clozapine is more common than previously
thought and may be even more common than with conventional neuroleptics. One study
found that 75% of patients gained at least 10 pounds over a 6 month period. Over a 3year period, more than 80% of patients increased their weight by 10% and over 38%
increased by at least 20% percent, thus posing a significant long-term health risk. The
mechanism of clozapine-related weight gain is uncertain, but as with conventional
neuroleptics, its effects are likely to be multifactorial. Clozapine affects the
histaminergic, cholinergic, endocrine, and metabolic systems, all of which can affect
weight. In addition, serotonin antagonists stimulate carbohydrate cravings and cause
weight gain.
There are a number of adverse gastrointestinal effects of clozapine including
sialorrhea, constipation, and nausea. Sialorrhea or excessive salivation, occurs to some
degree in most patients treated with clozapine, and tolerance does not usually develop.
Although hypersalivation is generally a benign side effect, patients sometimes describe a
choking sensation at night and may even aspirate excess saliva. In addition, drooling can
be socially embarrassing. The pathophysiology of sialorrhea is not clear. Constipation
occurs in 14% of patients treated with clozapine and can be severe. It is most likely due
to the anticholinergic properties of clozapine. Fiber supplements or unprocessed bran are
safe and effective in cases of mild constipation. Nausea tends to develop later in the
course of treatment and affects 11% of patients. The pathophysiological basis for this
symptom is also uncertain.
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Estimates of urinary incontinence have ranged from 0-30%. The mechanism is
unknown, but suggestions include excessively deep sleep related to clozapine sedating
properties, and urinary retention with subsequent overflow related to clozapine’s
anticholinergic properties.
Akathisia, a state of agitation, distress, and restlessness, has been reported in 639% of patients treated with clozapine. This stands in contrast to reports of the use of
clozapine as an effective treatment for patients unable to tolerate traditional neuroleptics
because of severe akathisia.
For many patients, clozapine offers new hope for successful pharmacological
management of a disabling mental disorder. However, up to 17% of patients must
discontinue treatment because of adverse effects. Therefore, managing these unwanted
effects is essential to a therapeutic outcome (Young, 1998). Furthermore, compliance
with clozapine can be significantly enhanced if patients are completely informed by their
healthcare providers about the nature and risks of its adverse effects.
Antidepressants in Schizophrenia
Because of the harsh side effects of clozapine, polypharmacology of
antidepressants and antipsychotics is often utilized rather than simply taking clozapine.
Rather than relying on clozapine, due to the side effects, many clinicians prefer
pharmacological treatments that are used in addition to antipsychotics including lithium,
anticonvulsants, sex hormones, glutamatergic drugs, acetylcholine esterase inhibitors, and
antidepressants. Antidepressants as adjuncts in schizophrenia are particularly under
extensive study and are, despite contrary evidence regarding their efficacy, already in
wide clinical use (Terevnikov & Joffe, 2013).
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The American Psychiatric Association suggests that antidepressants should be
used with caution in schizophrenia because of possible risk that sometimes an
antidepressant may exacerbate psychosis. However, recent research data shows that in
actual practice clinicians tend to widely use antidepressants to overcome the co-occurring
depression, posttraumatic stress disorder, anxiety, or schizoaffective disorder, negative
symptoms, and cognitive deficits of schizophrenia .
Antidepressants may reactivate neuroplasticity that is lost in schizophrenia.
Although antidepressants do not have antipsychotic properties, they may contribute to the
improved treatment outcomes in differences phases of schizophrenia. Many researchers
believe that this might be an underlying mechanism of positive results in a recent study.
In that study, antidepressants prevented conversation to psychosis in subjects with
prodromal schizophrenia symptoms more effectively than did atypical antipsychotics.
Another study found that add-on antidepressants treatment may become a useful option in
treatment of negative symptoms of schizophrenia. Specifically, the receptor-blocking
antidepressants has inspired more confidence than do antidepressants from other groups,
since their effect on negative symptoms seems to be rather consistent (Terevnikov &
Joffe, 2013).
Unfortunately, depressive symptoms are common in schizophrenia, and comorbid
depression significantly elevates the risk of suicide and negatively influences patients’
quality of life and level of functioning. Furthermore, at chronic stages of schizophrenia,
depression is associated with a higher risk for relapse. Typical antipsychotics are known
to even worsen depressive symptoms, and a considerable amount of atypical
antipsychotic treated patients with schizophrenia suffer from depressive symptoms as
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well. Therefore, antidepressants become an obvious pairing to combat the dangerous side
effect of depression (Terevnikov & Joffe, 2013).
Naturally, drug interactions must be considered when mixing antipsychotics and
antidepressants. Some drugs may inhibit certain enzymes, often causing unpredictable,
drastic, or even toxic increase in blood concentrations of medications metabolized by
these same enzymes. The role of these enzymes must be kept in mind when combining
antidepressants and antipsychotics. The most common mechanism of the interaction is
augmentation of the same neurotransmitter pathway. Another possible mechanism is
competition at receptor sites and a direct effect on an organ/system’s physiological
functioning (Terevnikov & Joffe, 2013).
The most common pharmacodynamic interaction side effects between
antipsychotics and antidepressants are: anticholinergic effects, extreme sedation, weight
gain, extrapyramidal symptoms, cardiac effects, vascular effects, and proconvulsive
effects. Although there are some side effects, it remains clear that antidepressants play an
important role for some schizophrenics.
Obstacles to Clinical Research and New Drug Development in Schizophrenia
Treatment of schizophrenia remains the arena in which all our science and all the
skills of clinicians are put to the ultimate test. Research to develop new treatments holds
enormous promise for the future (Kane, 1991). However, one cannot help but wonder
why clozapine, wrapped with all of its side effects, remains the gold standard in
antipsychotics. Why has a better, more effect drug not come to pass? Unsurprisingly,
there are difficult obstacles in this kind of clinical research.
Given the fact that schizophrenia is an illness that affects insight, judgement, and
other aspects of cognition, the ability of patients to give informed consent is often a
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legitimate concern (Kane, 1991). A related issue involves the fact that some patients do
not understand or accept the fact that they are ill or are in need of treatment and are
ultimately hospitalized against their will. To what extent can or should such patients
participate in research?
Not only do researchers deal with the challenge of finding samples, but challenges
inherent in drug development also exist. For example, during the early stages of the
testing of a particular drug, patients may be offered acute treatment in an experimental
protocol, but if they improve on the drug, they may not be able to continue taking it due
restrictions laid out by the FDA. Therefore, an enormously challenging tension exists
between the scientific aspects of establishing drug efficacy and the increasing demand
and expectation for the availability of experimental compounds outside treatment
protocols (Kane, 1991).
Furthermore, there is a selective premium that is placed on subjects whose central
nervous system neuronal receptors have not already been influenced by treatment,
particularly chronic treatment, with other agents--schizophrenics who are often not so
easy to find, due to the immediate prescription upon diagnosis (Kane, 1991).
Furthermore, the availability of accurate treatment histories can be an enormous problem
in clinical research. The inclusion in clinical trials of patients who, for whatever reason,
are unresponsive to treatments in general can also be a particular problem. This problem
is accentuated by the natural tendency for clinicians to want to offer experimental
treatments to those patients who have failed to benefit from other treatments. These
patients are often encouraged to join these trials by added incentives (Kane, 1991). The
fact that most pharmaceutical industry-sponsored trials provide financial support on a
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per-patient basis can also foster the temptation to bend inclusion-exclusion criteria,
sometimes leading to skewed results (Kane, 1991).
The very nature of schizophrenia also has an impact on the clinical resources,
facilities, and ancillary personnel necessary to maintain an environment conductive to
treatment research. In some psychiatric conditions, after an acute treatment phase,
patients may improve to such a degree that they require little follow up care. However,
this is rarely the case with schizophrenia. During or following participation in clinical
treatment trials patients normally require psychosocial and vocational therapies,
supportive living environments, family treatment, social clubs, jobs, and other support-all things that are often very expensive. While these problems are not an excuse for lack
of development, it is now easy to understand why scientists have found strife in
developing new drugs.
Psychosocial Treatments
While medications are very effective, the best treated individuals are those who
combine medicinal therapy with some kind of psychosocial treatment. There is a huge
variety of therapies available to choose from; therefore, the patient must choose what it
right for them. As I was previously noted, Elyn Saks relied heavily on a psychoanalyst
for treatment. Is this treatment right for everyone? Absolutely not, but for Elyn it worked
wonders. Again I reiterate, individuals must be able to choose what is right for them. In
this section I will present examples of psychosocial treatment models used today. They
include: shared decision making, cognitive behavioral therapy, assertive community
treatment, and familial involvement.
Shared Decision Making
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One summer during her time at Yale Law School Elyn Saks worked together with
her best friend at a halfway house for mental patients. It was here where Elyn became
passionate able mental health law. She worked for mental patients and children that
summer and from the experience she noticed:
“Psychiatric patients always have someone (or a whole chorus of someones)
telling them what they’re supposed to do. In my own experience, I had discovered
that it is much more effective to be asked what I’d like, e.g. ‘If you could arrange
things your way, what would that look like and how do you think we could help
you get there?’” (Saks, 2007).
Noncompliance of medication has been defined as, “a deviation or cessation of a
medication regimen that is less than what was recommended by a doctor.” Compliance
interventions are often designed for patients to conform to a doctor’s view of optimal
treatment. However, shared decision making diverges from this view and it assumes that
there are two experts, the patient and doctor, who share their respected information to
determine an optimal treatment option (Deegan & Drake, 2006). Shared decision making
with respect to medication is upheld by the values of recovery proposed by the Center for
Mental Health Services Administration in 2004.
The use of antipsychotics is often referred to as a journey, as patients often
approach these medications like scientists conducting a lay assessment of medication
effects--not just on their symptoms but on their quality of life as well. Therefore, the
compliance model, with its simple emphasis on obedience, is too basic to address the
complex process that is used to find an appropriate medication (Deegan & Drake, 2006).
When medications support or enable one to pursue activities such as employment,
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parenting, and returning to school, they are perceived by clients as a valuable asset to the
recovery process. On the other hand, if medication interferes with personal activities,
medications are then viewed as blocking the recovery process and are often rejected by
the patient. Therefore, insistence on compliance in this sort of situation is unhelpful.
However, shared decision making allows the patient to share with his or her physician on
what works for them and what does not (Deegan & Drake, 2006).
Like most things in life that involves the opinions of people, sometimes there is
tension between these perspectives. For example, a doctor may think that a medicine is
working well but the patient may no longer feel like themselves. This often results in
conflict where the doctor insists on compliance while the patient discontinues the
medication. Shared decision making allows the two parties to work together to achieve a
consensus to ensure a more positive and effective recovery (Deegan & Drake, 2006).
Cognitive Behavioral Therapy (CBT)
CBT is time limited and collaborative therapy that involves an individualized case
formulation approach based on functional analysis, routine monitoring of outcomes, and
assigned home practice between sessions (Marcus, 2016). CBT for psychosis was
developed with the underlying assumption that symptoms are maintained by both
appraisal and behavior and can be modified using CBT techniques. For example,
delusions are thought of as an attempt to make sense of negative affect and/or anomalous
sensory experiences, which result from an interaction between biology, cognition, and
behavior (Marcus, 2016). While not explicitly stated that they were using CBT
techniques, Lori Schiller’s therapists used several techniques of CBT on Lori before she
found full relief from clozapine.
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Within CBT, distressing hallucinations are conceptualized as products of a
person’s mind that reflect a propensity to access memories, internalized language, and
negative core beliefs. Impairments in source monitoring or the ability to monitor the
origin of one’s own thoughts, may play a role. The associated distress is amplified by the
experience of these phenomenon as alien, rather than coming from within one’s own
mind. Therefore, the goals of CBT include fostering a curious attitude about symptoms,
improving the sense of personal control over symptoms, decreasing distress, and
improving functioning and the acceptance of living with a difficult disorder (Marcus,
2016). Lori Schiller’s therapists used this idea on Lori:
“Dr. Fischer and Dr. Doller explained that, there weren’t really voices that other
people could hear. It was just my own hostile thoughts getting blown up out of
proportion inside my brain. I listened. I thought about it. No way, I thought at
first. I don’t have horrible thoughts like that. Those thoughts aren’t me. It’s those
Voices who are the crazy demons, not me… It seemed impossible to me that they
were simply figments of my own imagination. But gradually, with Dr. Fischer and
Dr. Doller leading the way, I began to test the waters… Once I began to be able to
tell my doctors what the Voices were saying about them, they began to help me
look more closely at what the Voices were saying and why” (Schiller, 1996).
Special attention to the engagement process of CBT is needed with individuals
suffering from psychosis. First and foremost, the clinician must lead with empathy,
convey expertise, and express hope that therapy can be helpful. Lori’s therapist, Dr.
Doller, did exactly this. Dr. Doller shares her philosophy of treatment in The Quiet Room,
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“We concentrated our efforts on getting inside the heads of our patients. Many
other treatments focused on using medication to alleviate symptoms. These
treatments were considered a failure if the patient was still hallucinating. We felt
otherwise. We felt that, hallucinations or not, there was still a person inside there-and that we could reach that person if we tried” (Schiller, 1996).
Many schizophrenics are often very secretive about their psychotic symptoms,
motivated by fear of involuntary hospitalization or of an increase in antipsychotic dosage
or even from direct messages from the voices that order them not to be spoken about to
the clinician. Furthermore, paranoia often makes it difficult to form a relationship for the
patient to form a relationship with a clinician. This is also evidenced in The Quiet Room,
“Dr. Diane Fischer, my new therapist is trying to kill me” (Schiller, 1996). Therefore,
CBT recommends at the onset of therapy, clinicians encourage clients to share suspicious
thoughts when they arise. In the early stages of therapy it is also important that the
clinician adopt a curious attitude towards the patient’s experience to help elucidate the
reinforcement behind a certain way of thinking about the world (Marcus, 2016). This is
also evidenced by Lori and Dr. Fischer’s relationship, “When I began to tremble, and
shake with fear, Dr. Fischer gently asked me to tell her what was on my mind. ‘Tell me
what you are hearing, Lori,’ she said” (Schiller, 1996).
One of the first aspects of implementing CBT are interviews that are conducted to
assess symptoms to create a case formulation. Assessment continues throughout
treatment, but the initial assessment typically comprises three or five of the first sessions
where the the patient and therapist work towards a shared case formulation. A basic care
formulation might include common triggers, thoughts, and behavioral responses
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associated with either the onset of or response to psychotic symptoms (Marcus, 2016).
The assessment phase also entails the development of a problem/goal list that provides
the blueprint for the goals of CBT. Often socially oriented goals are important, as social
support often decreases psychotic symptoms, preventing relapse (Marcus, 2016). Dr.
Doller also utilized this method for Lori, “First, we had to help her develop relationships
with people around her. People with schizophrenia are filled with an essential longing.
They have a longing to explain what is happening to themselves. And they have a longing
for a connection, for some a relationship that will give them a pathway back toward the
world they have lost” (Schiller, 1996).
In CBT, psychoeducation of symptoms, medication, and early warning signs can
help to reduce the feelings of powerlessness, provide needed clarity, and provide a
needed alternative for the reattribution of symptoms (Marcus, 2016). Dr. Doller also
implemented this strategy, “We felt that by trying to understand too. And by helping
them to understand, we could help them feel less overpowered and less terrified by their
symptoms” (Schiller, 1996).
Optimizing coping strategies for psychotic symptoms is a focus of CBT treatment.
In order to bolster coping, it is important that the clinician and client have a clear
understanding of how the client has typically responded to his or her psychotic
symptoms, the effectiveness of those strategies in reducing associated distress, and
whether these coping strategies have been associated with any problems (Marcus, 2016).
For example, to cope with command hallucinations is to comply with the instructions.
This strategy is often problematic for obvious reasons--self harm, legal problems, and
acting in a manner that goes against one’s values and goals. Therefore, the CBT therapist
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must conceptualize the behavior as maintaining the distress the patient feels, and together
with the patient identify ways to change these behaviors that are inhibiting normal
functioning (Marcus, 2016). The brilliant Dr. Doller used this method to help save Lori’s
life:
“Take Lori’s out-of-control behavior. Her record suggested that earlier doctors
had believed she was breaking things, smashing walls and running away on
purpose. They believed her behavior was under control. They believed she was
manipulative, attention-getting, and locked in a power struggle with staff that
could be handled only through strict discipline. I chose to believe otherwise. I saw
her behavior as an understandable response to her scary inner world. As I
observed her, I could see how she would get. As she spiraled out of control, we
could begin to talk to her… But she couldn’t hear. This woman wasn’t playing
mind games. This woman was in genuine distress. And how would she have any
idea how to handle that distress without being taught?” (Schiller, 1996).
Dr. Doller saw her job as teaching Lori to recognize her symptoms as phenomena, and to
seek help immediately before the symptoms became too much for Lori to bear. This is
precisely the aim of cognitive behavioral therapy.
Assertive Community Treatment and Familial Involvement
Assertive community treatment (ACT) provides a comprehensive range of
treatments, rehabilitation, and support services through a multidisciplinary team based in
the community. Basic characteristics of ACT programs include assertive engagement
(delivery of social services that is effective even for the hardest to reach clients and
families), a multidisciplinary team approach, continuous responsibility, staff continuity

84

over time, caseloads with high staff-to-client ratios, and brief but frequent contacts (Scott
and Dixon, 1995). ACT teams also provide a close liaison with the client’s support
system and a treatment focus on alternative activities. There is strong and consistent
evidence that ACT reduces the rate and duration of psychiatric hospitalization. ACT
programs reduce psychiatric symptoms, improve social functioning, and promote
residential stability and independent living. ACT has also been shown improve
compliance with treatment and is well accepted by patients (Scott and Dixon, 1995).
When I spoke with Dr. Bitner, he noted that assertive community treatment has been very
successful with his patients. On the effectiveness he remarked, “These patients cannot
help themselves without the community behind them. Treatment today takes the whole
village” (personal communication, April 7, 2016).
Family psychoeducation is an evidenced-based practice that has consistently been
shown to reduce relapse rates for schizophrenia (Weisman et al., 2006). For instance, a
meta-analysis conducted in 2001 strongly indicated that relapse rates for patients with
schizophrenia can be drastically reduced if patient’s family members are included in the
treatment. However, most mental health facilities still lack family treatments of any type.
During my conversation with Dr. Bitner he was sure to emphasize that families of his
patients can also be very ill. He noted the importance of family support groups so that
family members get a chance to air their grievances is often crucial to the success of the
patient’s treatment (personal communication, April 7, 2016). Expressed emotion is a
widely used measure of the emotional climate of a household, specifically assessing
relatives’ critical, hostile, and emotionally overinvolved attitudes towards patients. Not
surprisingly, a mounting body of research indicates that the course of schizophrenia is
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highly correlated with the familial atmosphere. Many studies have indicated that
returning home to a hostile, critical, or emotionally overinvolved environments can
substantially increase chance for relapse, hence the importance of familial support
groups (Weisman et al., 2006).
Early Intervention
Today’s treatment model for schizophrenia is the best it has ever been. However,
prominent researcher on early intervention, Patrick McGorry, asserts that stigma and
pessimism have dominated therapeutic efforts to ensure that treatment efforts become
delayed and inconsistent. On the contrary, McGorry cites that early intervention
techniques in treatment have seen an explosion of sorts in research and effort.
The advent of preventative thinking in psychosis has required a shift in the way
schizophrenia and other disorders are viewed. Rather than seeing them as having
inevitably poor prognoses with deterioration in social and functional outcome as the
norm, more recent thinking backed up by evidence from large international studies views
the course of these disorders as being very fluid and malleable (McGorry et al., 2008).
Examination of the risk factors which can influence outcome has revealed that many
symptoms may be reversible. For example, disruption of peer and family networks and
social dropout typically occur around and even before the onset of a first psychotic
episode. Attention to these areas as part of treatment has the potential to limit or repair
the damage (McGorry et al., 2008).
Early intervention can be a potentially confusing term. There are no known
flexible causal risk factors that predict the onset of psychosis. Therefore, primary
prevention is out of reach. Therefore, all prevention in early intervention is actually
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secondary (McGorry et al., 2008). Early intervention in psychosis can be defined as
comprising three stages: ultra-high risk, first episode, and the recovery or critical period.
This is called a clinical staging model. It helps to provide a framework that allows for the
development and evaluation of broad and specific interventions as well as the study of the
variables and processes underlying the evolution of psychiatric disorders (McGorry et al.,
2008). Put simply, clinical staging is a more refined form of diagnosis. It differs from
conventional diagnosis practice in that it defines the extent of progression of disease at a
particular point in time, and where a person lies currently along the continuum of the
course illness. It enables clinicians to select treatments relevant to earlier stages, and
assumes that such interventions will be both more effective and less harmful than
treatments delivered later in the course (McGorry et al., 2008).
Defining discrete stages according to progression of disease creates a preventionoriented framework for the evaluation of interventions. The key positive health outcomes
are prevention of progression to more advanced stages. This requires an accurate
understanding of those broad social, biological, and personal risk and protective factors
which influence progression from one stage to the next. Risk factors for each stage can
begin to be identified, and while some risk factors may operate across all stage
transitions, others may be stage-specific, for example, substance abuse and stress may be
especially harmful in triggering the onset of the first episode of illness, but can be less
toxic in later stages (McGorry et al., 2008).
A key aspect related to early intervention methods is beginning to be more
recognized: it is that mental disorders are the chronic diseases of the young. Most adult
type mental disorders like schizophrenia have their origins in late adolescence and early
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adulthood (McGorry et al., 2008). Therefore, developed countries need to recognize the
public health importance of untreated and poorly treated mental disorders. McGorry
further emphasizes that early diagnosis and intervention can change many of the issues
faced by schizophrenics during their diagnosis and treatment process.
Invisible Wounds: Issues faced by Schizophrenics
Unfortunately, we live in a society that does not take kindly to mental illness, and
schizophrenics, in all of their suffering, often face more suffering, as society struggles to
understand their illness. Moreover, early intervention techniques are still in their infancy
in the United States; therefore, many schizophrenics continue to suffer in their diagnosis
and treatment. When the disease arose in the early 20th century in literature and in the
public, state mental hospitals were implemented to care for people who could not care for
themselves alone. While there is no hiding the fact that the early history of these hospitals
was grim, horrible even, they served an important purpose for society. With the rise of
deinstitutionalization, came an increasing number of homeless and criminalized
schizophrenics, as public policy officials did not follow up on their promises to create
more community based treatment centers. If schizophrenics are left untreated, they are at
an immensely increased risk of drug abuse and suicide, as Lori Schiller’s story so
chillingly depicts. Increased criminality, drug use, and homelessness, are all issues
related to schizophrenia that are the result of uneducated and misinformed societal
choices. In addition, these problems further contribute to the stigma that has infiltrated
mental illness for much of the 20th century and now, a far too large, portion of the 21st
century. Most of society relates this stigma to the “inherent violence” associated with the
mentally ill. When in reality, stigma ultimately relates solely to the inherent ignorance of
society.
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Deinstitutionalization
State hospitals were once the most prominent components of the United States
public mental health systems. A major focus of mental health policy over the past fifty
years has been to close these facilities. These efforts led to a 95% reduction in the
country’s state hospital population (Fisher et. al, 2009). Eliminating state hospitals
continues to be a goal despite the enduring importance of the services they provide.
Forces that worked for the changed role of state hospitals often called for more
community based care or solutions (Fisher et. al, 2009). However, often the role of state
hospital’s has been to provide care for those people deemed inappropriate for placement
in an alternative mental health setting for behavioral reasons (Fisher et. al, 2009).
The closures of state hospitals began with president John F. Kennedy’s
Community Mental Health act that was enacted in 1963. Where President Kennedy’s
legislation went wrong was that it failed to recognize the role that state hospitals had in
managing the population of people that has been deemed inappropriate for normal
societal expectations and settings. These patients, often schizophrenics, were often
labeled “difficult to discharge.” With nowhere else to turn at the closure of a hospital,
these schizophrenics are often left on the streets or in jail (Fisher et. al, 2009). Since the
1970’s, attention has been focused on the increasing rates of arrest and incarceration
among people with mental illnesses who use state hospitals and other mental health
services. A recent Massachusetts study of the arrest patterns of the state mental health
agency’s clientele found that nearly 30% of a cohort of nearly 14,000 people experienced
state hospital stays, and they had been accused of recent charges, including mostly drug
and nonviolent offenses. These charges likely complicated their housing arrangements,
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employments, and other aspects of successful hospital discharge and community
integration (Fisher et. al, 2009).
In line with President Kennedy’s plan, in the late 1990’s many state hospitals
diverted their funds to expansions of community-based services. However, if
schizophrenics do not successfully enroll in community-based treatment they remain at
an increased to fail to comply with their antipsychotics, thus placing them at a higher risk
to wind up on the streets or in jail.
Homelessness
A 2009 survey by the National Institute of Mental Health found that 20-25% of all
homeless people in the United States suffers from mental illness. There has been an
association with schizophrenia and homelessness for decades, and such an association
does not solely exist in the United States. It has transcended into the United Kingdom,
Europe, and Australia (Timms, 2005). Homelessness can take many forms. At one end of
the spectrum are those sleeping outdoors, sleeping in abandoned buildings, or using
hostels and night shelters. At the other end of the spectrum are the ‘hidden homeless’
who seek refuge with family and friends. (Timms, 2005).
The earliest scientific literature connecting schizophrenia to homelessness was a
survey from one a police warehouse to a local asylum that revealed a large number of
homeless men and women were also afflicted with schizophrenia. Unfortunately little
progress has been made on this issue, as the most recent studies have found that homeless
people with schizophrenia tend to have no current contact with mental health treatment
services (Timms, 2005).
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There are many explanations for the connection between homelessness and
schizophrenia. Most notably, the United State has the deinstitutionalization of state
hospitals to blame. While these social issues are certainly a part of the problem, the
untreated symptoms of the disease themselves contribute to the problem of homelessness
as well (Timms, 2005). For example, social withdrawal is often one of the early
symptoms of schizophrenia. This withdrawal reduces the ability or likelihood that family
or friends will lend the necessary support. Symptoms of schizophrenia also interfere with
an individual’s ability to cope with everyday life. For example, auditory hallucinations
and delusions have the potential to make a schizophrenic individual believe that he or she
was meant to be or deserves homelessness (Timms, 2005).
To add to this already unfortunate issue, the schizophrenic homeless population
has become much younger, and many researchers have found higher rates of alcohol and
drug abuse within the population. Nevertheless, actions are being taken to ensure that the
connection between schizophrenia and homeless dissolves in due time. These changes
have most importantly included implementing early intervention tactics, thereby reducing
the number of new arrivals on the street (Timms, 2005). Volunteers in the United States,
the United Kingdom, Europe, and Australia are also working to prevent dropout from
mental health services. This is being done by establishing assertive community
treatment. Volunteers often seek out patients who do not turn up for appointments,
ensuring they do not fall through the cracks that lead to homelessness. Volunteers are
also now working with programs that engage with those who are already homeless
through mediums like street outreach teams, community hospitals, and temporary
accommodation (Timms, 2005). The relationship between homelessness and

91

schizophrenia undoubtedly remains a problem today. However, the issue is being
seriously addressed by updated, more effective treatment models. Nevertheless, these
treatment models have to get the needed funding to stay in operation, often a major
impediment for many communities.
Criminality
As was evidenced in Kurt’s story, situations can arise when schizophrenics
wonder the street with their delusions and hallucinations leading them astray. As
evidenced by Kurt’s account, dramatic things can happen, like his breaking into
someone’s home while on vacation in Montana after he suffered from a cat scratch that
he believed was “a poison dart inserted by bad CIA agents” trying to kill him. He broke
into a home with the idea of finding something sharp to remove the “dart” with. Kurt did
not believe anyone to be home, but he turned out to be very wrong. The residents were
home, and they called the police. Thankfully, both the residents and the police understood
that Kurt was very mentally ill, and they took him to a hospital, rather than jail (Snyder
59-62). Other schizophrenic individuals are not so lucky, and their criminalizing
delusions like this land them in jail time and time again, often for similar nonviolent
crimes.
Researchers Modestin and Ammann conducted a study that examined
schizophrenia and criminality in males afflicted with schizophrenia to better understand
the connection between crime and the disease and how it might be resolved in the future.
The researchers cite prior studies that note correlations between criminality and lack of
active treatment, delusions, noncompliance with antipsychotics, substance abuse,
homelessness, and prior arrests (Modestin & Ammann, 1996). In a general population
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birth cohort study, men with a major mental disorder, including schizophrenia, were
found to be 2.6 times more likely to have been convicted of a criminal offense than
healthy men and were registered for more crimes. Mentally ill offenders are more
frequently arrested and shifted into the penal system because of unavailability of mental
health care, more rapid discharge from psychiatric hospitals, refusal of these hospitals to
admit dangerous patients, lack of beds, lack of resources, etc.
Notably, Modestin and Ammann found that differences between the patients and
the controls appeared when individual crime categories were considered. For example,
patients were 2.5 times more likely to have been convicted of crimes against property and
almost 3 times more likely to have violated drug laws. The researchers also found that
59% of the patients with a criminal record had been criminally convicted before their first
psychiatric hospitalization and 41% afterward; therefore, the beginning of the criminal
behavior was quite equally distributed around the time of the first psychotic episode
(Modestin & Ammann, 1996). Unfortunately, issues that schizophrenics face often lead
them to becoming confined to a jail cell, rather than obtaining proper mental health care.
Substance Abuse
As the researchers Modestin and Ammann found, illegal substance abuse leads
too many schizophrenics behind bars. This means that many schizophrenics not only deal
with the mental stress of the disease but also deal with the mind games of drug addiction.
Comorbid substance abuse disorders have emerged as one of the greatest obstacles to the
effective treatment of persons with schizophrenia (Warner et al, 1994). Lori Schiller’s
battle with cocaine began soon after she was released from the hospital after she landed a
waitressing job. She laments,
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“Those little pills or a quick snort on the other hand could make me feel
incredibly relaxed when the Voices were making me tense. But drugs had never
been a big part of my life until I got out of the hospital… All I was trying to do
was feel better. The medications they gave me in the hospital were useless… And
the Voices still raged away at me, mocking the drugs, the doctors and me.
Cocaine, on the other hand, helped me ignore the Voices” (Schiller, 1996)
Lori’s only goal was to get high and avoid the crash that would inevitably come.
The odds of having a substance abuse diagnosis were found to be 4.6 times higher
for persons with schizophrenia than for the rest of the population; the odds for alcohol
disorders have been found 6 times as high (Warner et al, 1994). Researchers Warner et.
al. uncovered that schizophrenics have been found to have a heavier pattern of use of
marijuana, LSD, and amphetamines. Previous studies argue that drug dependent
schizophrenics, like Lori, use substances to self-medicate painful affective states and
other psychiatric symptoms. Other researchers reported that patients with major mental
illness may try to use a variety of substances to control depression. For example,
schizophrenic inpatients interviewed during a 1990 study reported that various substances
were effective in reducing depression and anxiety, increasing energy, or alleviating
negative symptoms of schizophrenia, but that these substances could also increase
suspiciousness and hallucinations (Warner et al, 1994).
Previous studies have noted that substance abusing mentally ill patients appear to
be less compliant with medication use, a difference that may contribute to the worse
pattern of illness. Therefore, researchers Warner et al. developed a study to evaluate
substance use in an outpatient population whose medication compliance was well

94

controlled by assertive community treatment. To conduct this study, seventy-nine
psychotic patients were randomly selected from the caseload of a comprehensive
community mental health center. Most patients were afflicted with schizophrenia or
bipolar disorder. A confidential interview was conducted. The results from the Warner et
al. are staggering. They found that the lifetime prevalence of use of marijuana in the
study sample was 89.1%. For hallucinogens and stimulants it was 61.8% and 60%,
respectively. The researchers noted that hallucinogen use by the mentally ill sample was
substantially greater than the general population sample. In addition, nearly 90% of
subjects had used marijuana, compare that to the college-age control sample of 61%. The
same is true for hallucinogens (over 60% versus 15% of college-age subjects), cocaine
(49% versus 24%), and other stimulants (51% versus 27%) (Warner et al, 1994).
Although these findings are quite dreadful, the researchers found that substance
use may become less frequent when mental illness is better controlled, and improvements
in this sample may be related to provision of intensive case management and daily
monitoring of medication, prevention of relapse, money management--restricting the
opportunity for patients to purchase large amounts of drugs or alcohol (Warner et al,
1994). Lori’s story can also attest to these results; when her illness was controlled, he
turned her back on cocaine. She testifies in the epilogue of The Quiet Room, “As for
drugs, real drugs, street drugs, I have never taken up the offer to get high with anyone
since the cocaine incident at [the halfway house] years ago. I’ve come too far and
accomplished too much to waste it all by sliding back into the shadowy world of drugs”
(Schiller, 1996).
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Like Lori, the subjects in the Warner et al. study cited social interaction, relief of
unpleasant affective states, and boredom as the principal reasons for substance use. Many
subjects also noted a feeling of improved self-esteem. Subjects who preferred
hallucinogens, as they were cited to help the subjects “stay awake” and to “feel better
physically”. The effects of antipsychotic medications were also said to be relieved or
lessened with the use of hallucinogens (Warner et al, 1994). Subjects who preferred
marijuana used it to reduce anxiety and boredom, and these subjects were often found to
have little structured daily activity. This observation indicates that work and activity
programs may be helpful in reducing marijuana use among the mentally ill (Warner et al,
1994). As evidenced by Lori’s account and by the results from this study, drug use is a
problem that persists in society. It is also a large contributor of jail time for
schizophrenics as well; therefore, drug use needs to be more fully addressed in our
society so that schizophrenic can get effective treatment they need to live more fulfilling
and safer lives.
Suicide
Unfortunately, there are situations in which some or all of the issues of
schizophrenia I have listed above compound on a single individual until that person feels
totally hopeless. Not only did Lori Schiller deal with drug use, she attempted suicide a
staggering four times. When Lori was home with her parents in between her major
hospital stays, suicide was often on her mind, “My head swarmed with suicidal fantasies”
(Schiller, 1996). She shares many of her suicidal thoughts in the memoir. They are vivid,
fascinating, but mostly very disturbing:
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“I didn’t want to just take an overdose or slit my wrists. I wanted something
powerful that would reflect the despair that haunted me every day of my life. As
the pressure of those thoughts built, my imagination went wild seeking ways of
accomplishing my aims. I thought about jumping in front of a car, or better yet, a
truck; or even better yet, a train. I thought about jumping out of a moving car onto
the highway. I thought about standing on a bridge, pouring a can of gasoline over
my head, lighting a match, and jumping in the flames to my death. Splat. Rocks in
a bathing suit, then the ocean? How about jumping into a vicious animal’s cage in
the Bronx Zoo” (Schiller, 1996).
It is nearly impossible to fathom what it must be like to have such terrifying thoughts.
One wonders what might even cause such thoughts. Lori’s Voices were pure evil, “The
Voices would alternatively chant, ‘To die! To die! To die!’ and then ‘Peace! Peace! They
are waiting to give you peace!’ There was only one route to peace. The pressure was
building. Finally, it became unbearable. I had to act” (Schiller, 1996).
Living with such Voices is inconceivable to most; therefore, it comes as no
surprise that many schizophrenics, like Lori, cannot deal with their illness and feel that
their only escape is suicide. It is estimated that about 5% of schizophrenia patients
commit suicide and a considerably greater portion attempt suicide at some point of the
illness, with estimates varying in the range of 20%-40% (Kjelby et al, 2015). The most
established clinical risk factors for suicide in schizophrenia include depressed mood,
hopelessness, previous suicide attempts and fear of mental disintegration. Other risk
factors, some shared with other psychiatric disorders, include younger age, early stage of
illness, good premorbid adjustment of functioning, male gender, married status, living
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alone, unemployment, substance abuse, higher intelligence, having awareness of/insight
into disease, recent loss, access to lethal means, poor adherence to treatment and recent
admission to hospital.
Researchers Kjelby et al. found that the evidence concerning the influence of
positive psychosis symptoms such as hallucinations and delusions, on suicidal behavior is
not extensively described in current literature. However, hallucinations are prominent and
often dramatic symptoms during the acute phases of schizophrenia. Much of the current
literature also indicates that delusions are not a substantial risk factor for suicide;
nevertheless, there are numerous case reports and a few studies that describe completed
suicides and very serious self-harm in the extreme psychotic and delusional states.
Therefore, taken together, researchers Kjelby et al. assessed that roles of hallucinations
and delusions remain unresolved in schizophrenia-related suicidality research.
To conduct their study of the relationship between suicide and hallucinations and
delusions, 124 patients suffering from schizophrenia were assessed. The primary aim was
to determine the risk attributed by hallucinations and delusions on suicidal ideation and
plans and attempts. In their analysis they found that depression, drug use, hallucinations,
and negative symptoms were associated with suicidal ideation. Only depression and
hallucinations were significantly associated with suicide plans. Increased suicide-risk in a
hallucinating patient may be related to the hallucinations devaluing the patient or voices
encouraging self-harming behavior. These results indicate a relationship between
hallucinations and suicidal ideation and suicide plans (Kjelby et al, 2015). As expected,
depression was the factor in the study that increased the chance of suicidal ideation and
suicide plans most markedly. Depression, drug use, and hallucinations increased the
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chance of suicide symptoms and negative symptoms reduced the change of suicidal
symptomology. This study aimed to warn against underestimating the risk contributed by
hallucinations on suicidal ideation, plans and attempts. The suffering and human cost due
to suicide attempts may be substantial and the prevention of suicide ideation and attempts
in themselves is in its own term highly important (Kjelby et al, 2015).
Researchers Jovanovic et al. created a study to explore the association between
psychopathology and suicidal behavior in patients with schizophrenia, acknowledging
three groups: suicide ideators, suicide attempters, and participants without suicide
ideation and behavior. A previous study showed that during the first year after suicide
attempt, the active form of the disease was present in 78% of participants, depressive
symptoms in 64%, previous suicidal attempts in 71%, and command hallucinations in
10% of participants.
Jovanovic et al. found that a higher percentage of suicide attempters were
unemployed or retired and a much lower percentage complied with the treatment in terms
of regularly using their antipsychotics. There was a higher percentage of men in the
groups with suicide ideation or attempt. Suicide ideators were on average somewhat
younger than those without suicide ideation. Suicide attempters had greater mean
numbers of institutional admissions than the other two groups. They were also more
depressed than suicide ideators. Jovanovic et al. also found that only negative symptoms
were found to discriminate among the patients. In comparison to the group of patients
without suicide attempt or ideation, some of the negative symptoms were slightly higher
in the groups with suicide ideation or attempt (e.g., social withdrawal and
passive/antisocial withdraw) (Jovanovic et al, 2013). This study’s results are in
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accordance with other studies that depict suicide behavior in schizophrenia not as related
to psychotic symptoms such as delusions and hallucinations as it is to depressive mood.
The majority of suicide attempts in the study happened during an ongoing psychiatric
treatment and the odds of suicide attempts increased with the number of prior
hospitalizations. This might indicate that these participants suffered from a greater burden
of symptoms but it might also be argued that if these patients tend toward suicide
behavior, this tendency itself would increase the likelihood of hospitalization independent
of illness severity (Jovanovic et al, 2013). Like many of the issues listed above, suicide is
very much preventable with proper treatment.
Stigma
“Mental Illness comes with stigma attached to it, and that stigma can set off a negative
reaction, even from the nicest people, with good intentions and kind hearts. Even for
many of these people, those with mental illness are other; they're not like ‘us.’” -Elyn
Saks
In light of recent events in the United States, most Americans have an outlook on
the mentally ill that, in all honesty, cannot be further than the truth. People believe that
schizophrenics are violent, dangerous, wacko, insane, crazy, etc. When most
schizophrenics live a life much like my Aunt Linda, in a group home, medicated, and in
reality, quite tame. Nevertheless, I can almost assure that if young people in the United
States were to name a face of schizophrenia, people like my Aunt Linda would not come
to mind. Instead, they would point to those like James Holmes, the man responsible for
the movie theater massacre in Aurora, Colorado. First, I want to firmly reiterate that the
violence that Holmes committed is inexcusable, unforgivable, and heartrending. Be that
as it may, I would like to take a further look into James Holmes’s mind to illustrate that
societal stigma and lack of treatment are a deadly combination that must change.
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First, I would like to establish some of the evidence that lead me to believe that
Holmes suffers from schizophrenia symptoms. I should point out that his formal
diagnosis from the court-appointed psychiatrist on his case is schizotypal personality
disorder. Nonetheless, the World Health Organization recognizes it as a disorder that that
is very closely associated with schizophrenia. The disorder is differentiated from
schizophrenia by extreme social anxiety. According to a CNN article on Holme’s
psychiatrist, his first visit was scheduled under reference of none other than extreme
social anxiety. I would also like to point out evidence to schizophrenia symptoms from an
ABC news article that came out in the early summer of 2015 in light of his trial: he
suffered from both auditory and visual hallucinations. He claimed to see “flickers” of
shadows of axes and guns out of the corners of his eyes. He also claims to have heard
voices, though these voices did not tell him what to do, instead they were “talking about
him in another room.” To which I wonder if his voices were anything like Lori Schiller's
Voices? What if he had had a therapist like Dr. Doller who took extreme, concerted
action to change his disorganized thought process?
Holme’s journal, which he entitled his ‘Course of Life,’ recounts this life, ideas,
and thought processes up until the massacre in July of 2012. The journal was made public
in the summer of 2015, following his trial. Upon reading the contents of the journal, one
is vehemently aware of his illness. In combination with a broken mind, this man was
suffering from a multitude of horrors that included extreme social isolation. His childlike
writing composes page after page of his self diagnosis of a broken mind. Some of his self
diagnosed symptoms are undoubtedly some of the insignias of schizophrenia: catatonia,
social isolation, inability to communicate with others, difficulty concentrating, “odd”

101

sense of self, and finally delusional thoughts on homicide are mentioned to which he
wrote, “the obsession to kill.” He follows his self diagnosis with narrative that says, “And
finally, the last escape, murder at the movies. Obsession onset > 10 years ago. So
anyways, that's my mind. Its broke. I tried to fix it.” The journal continues with bizarre
and complicated loose associations, made up symbols, 7 entire pages of the word ‘why?’
written over and over again, and finally his plan of mass murder. After finishing
Holmes’s journal, which was by and large the most disturbing piece of writing I have
ever read, my only response is, why has our society allowed someone to feel like their
only escape is mass murder? Why are individuals with schizophrenia like, Elyn, Lori,
Kurt, and finally Holmes so afraid to admit their symptoms to people who can offer
treatment or help? To address the seven pages of ‘why?’ in the journal. I need only
conclude with one word: stigma.
Many are quick to point out that Holmes had received therapy up until about three
weeks before he committed the shootings. Many have posed, if he was receiving
treatment, why did this happen? To which I would respond, “Was he diligently taking
medication?” According to the ABC news article that came out just after the trial, he was
not on medication the night of the murders. In his journal he jots that his psychiatrist
immediately prescribed antidepressants but he felt “no effect.” According to the CNN
article on his previous psychiatrist, Lynne Fenton, when she wrote his prescription, she
got his name wrong--prescribing it to “James Hughes.” This was most likely extremely
detrimental considering Holmes already had deep feelings of hatred towards society.
Who could even imagine how Holmes felt after even his therapist could not remember
his name? By now, I am sure that it is obvious that the events of July 20, 2012 might not
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have unfolded had James Holmes been on a steady regimen of antipsychotics, and the
correct antipsychotic at that. What if he had been on clozapine? Would he have
responded as miraculously as Lori Schiller? In addition, how could he have benefitted
from programs like assertive community treatment? I can only guess that it might have
significantly improved his feeling of social isolation, and it would have definitely ensured
that he was getting effective medicinal treatment.
Similar to Lori Schiller, Holmes was described as hostile, anxious, and “not very
forthcoming” by his psychiatrist, Lynne Fenton. She notes that from his very first session
with her he described homicidal thoughts, but she never believed he would act on them.
In fact, she told police that she tried to form an alliance with Holmes to ensure that he
would continue counseling and continue taking his medication. This sounds quite
rational. However, during their last session even she grew to fear him, noting an “angry
edge” according to CNN. Instead of the police, she called his mother who responded
with, “Yes, he's been troubled for many years.” Which leads me to wonder why the only
prior psychiatric help before Fenton he had was a family therapist in childhood, despite
his showing of early warning signs that include childhood night terrors and obsessions
with homicide beginning as a teenager. In his journal, Holmes wrote that “He revealed
nothing to the family therapist, so that he would not appear weak to his family.” One can
only assume that had James Holmes felt comfortable sharing his madness earlier, his
parents might have further employed the basis of early intervention with respect to his
psychosis, and the events of July 20, 2012 might not have come to light at all. Likewise,
what if Holmes had not fallen victim to the deceitful idea that mental illness means
weakness?
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Despite efforts to get help, Holmes was not treated effectively. Holmes did not act
randomly, his actions were premeditated down to the last detail. Making one wonder how
he even slipped through the cracks to pull this off? Regardless, in his broken mind he is
now “known for something” thanks to the media frenzy that surrounded his case. The
mentally ill fascinate us, so the media preys on them, thus further perpetuating ideations
of violence and criminality associated with them. The day after it happened, when my
family was caught up in the media’s circus, my mom look one look at Holmes’s large,
expressionless eyes and dyed orange hair and said, “That man is a monster.” While she is
not wrong, I must pose the question: what created the monster?
I presented Holmes’s case to illustrate that our society is the monster that needs to
change so that we can begin to accept the realities of mental illness and get these people
the help they need before they end up homeless, in jail, addicted to drugs, committing
suicide, or in a very small percentage of cases, mass murder. First and foremost, I would
like to inquire why mental illness policies are consistently called into question upon mass
shootings? Politicians are quick to deflect gun control conversation to mental illness, but
are not so quick to actually draft appropriate legislation to fix the problems the mentally
ill face. In the words of John Oliver of the satirical political program Last Week Tonight,
“It seems there is nothing like a mass shooting to suddenly spark political interest in
mental health.” Oliver goes on to condemn former governor of Arkansas, Mike
Huckabee, for his comment on CNN in light of the recent shootings at an Oregon
community college during the early stages of the 2016 presidential race. Huckabee
incited “Do we need to do a better job in mental health? You bet we do.” Oliver rebuttals,
“It’s worth noting that Governor Huckabee’s state got a D- in mental health care when he
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was in office, and you can’t lecture people in something that you got a D- in.” The real
issue, as presented by Oliver, is that the entire political system that emcompasses mental
illness needs a complete overhaul. True to most topics related to schizophrenia, such an
undertaking will not be easy due to the fact that there are hundreds of programs involved:
medicaid, 8 federal agencies, 112 different programs associated, and the social services
programs in each state. Oliver finishes the segment by citing the effectiveness of assertive
community treatment programs: “Doing everything it takes for people to stay healthy is a
lot better than what we’ve been trying, which is nothing, not anything, very few things,
not much, and prison.” Unfortunately, assertive community treatment and many other
programs I have cited are in danger of budget cuts; however, these programs often pay
for themselves. Consequently, Oliver emphasizes that, we as a society must figure out
how to pay for them, because they save lives.
Moreover, we must ask ourselves how often the mentally ill are actually related to
gun violence. Although it may seem like a lot, due to the attention from the media and
opportunistic politicians, in reality fewer than 2% of mentally ill individuals are
considered violent (Choe et al., 2008). Oliver contests during the same segment that when
mental illness is talked about in light of mass shootings, it is seriously misleading-compare the 2% of violent crimes attributed to the mentally ill to the 40% of arrests for
serious violent crimes that belong to the cohort of males under 24 (Choe et al., 2008)
In a recent study that examined this perpetuation of violence, researchers Choe,
Teplin, and Abram suggest that data must be collected on the mentally ill who are not
receiving treatment. These researchers also cite the need to disentangle the causal
relationships between severe mental illness, victimization, and perpetration. Choe,
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Teplin, and Abram then created a model whereby social disorganization and poverty, a
phenomenon common among many persons with severe mental illness, increase a
person’s vulnerability to victimization and their propensity to perpetrate violence.
Repeated victimizations may lead to suspicion and mistrust, which in turn may lead to
conflictive and stressful situations--creating the vicious cycle of victimization and
perpetration (Choe et al. 2008).
The researchers recommend the following steps to stop the cycle: encourage
mental health centers to assess the risk of victimization and perpetration in their
communities and create interventions that provide information on substance abuse,
homelessness, medication adherence, and conflicted relationships to help the mentally ill
equip themselves with the proper tools to enhance personal safety and reduce conflict
(Choe et al., 2008). The researchers conclude by voicing that the media has an enormous
power to reduce stigma, rather than propetuate it, through a plethora of mediums: TV,
magazines, social media, etc., because at this point, there is no excuse for keeping the
public uneducated and misinformed (Choe et al., 2008).
Personal Stigma
Stigmatization cannot be fully understood without taking into account the
subjective perspective of people with mental illness, as they very clearly play an active
and important role in this process (Switaj et al., 2014). The subjective perspective is often
referred to as personal stigma, as opposed to public or societal stigma. Three main
aspects of personal stigma are distinguished: perceived stigma, experienced stigma, and
internalized stigma, the process of the internalization of stigmatizing societal attitudes,
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resulting in fear of discrimination, social withdrawal, feelings of shame, guilt, and
hopelessness, and a decrease in self-esteem(Switaj et al., 2014).
Elyn Saks writes eloquently and often about how stigma has affected her life in
The Center Cannot Hold. She recounts,
“There were whole parts of myself that I tried desperately to keep hidden. I knew,
for instance, not to share my ongoing delusions of evil, in particular the part about
my being evil and my total certainty that I was capable of horrible acts of
violence. Not that these thoughts were wrong; I believed everyone thought this
way, but just knew better than to talk about it.” She continues, “One of the worst
parts of schizophrenia is the profound isolation--the constant awareness that
you’re different, some sort of alien, not really human. Other people have flesh and
bones, and insides made of organs and healthy living tissue. You are only a
machine, with insides made of metal” (Saks, 2007).
Elyn’s words are dismaying. Therefore, we must ask ourselves how we can change
individual thoughts and actions; we must ask how we can be a friend to help raise self
esteem and self worth in order to save lives.
A study conducted by Switaj et al. sought to examine what socio-demographic
and clinical variables are most prominently related to the intensity of stigma reported by
people with mental illnesses and to determine how various aspects of personal stigma
contribute to the impact of stigma. The researchers found that the participants most often
felt internalized stigma followed by perceived stigma followed by actual stigmatizing
experiences. Within the sample, the factors most associated with greater impact of stigma
were a schizophrenia diagnosis (as opposed to any other mental illness), current inpatient
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treatment, experienced stigma (bullied, denied rights, etc.), and internalized stigma
(social withdrawal) (Switaj et al., 2014).
This study's findings add to the extent of literature demonstrating that self-stigma
and experienced stigma can negatively influence personal and family life. Hence,
counteracting their pernicious effects is crucial for the improvement of the well-being of
people with mental health problems. The researchers recommend that the interventions to
reduce internal stigma need to enhance an individual’s self-esteem, empowerment, and
help-seeking behavior.
Stigma in Healthcare
Next, I would like to draw attention to the last clause of the previous section that
states interventions need to reduce stigma to improve help-seeking behaviors. Stigma
negatively impacts almost every aspect of the lives of the mentally ill, including whether
or not they seek treatment from healthcare professionals. Upon reading the stories of
Elyn, Lori, and Kurt, I was taken aback by how each of them were treated in healthcare
settings. The language that they use to describe their hospitalizations is frightening,
leading me to surmise that their unjust treatment while in the hospital was due to
misunderstanding and stigma from people who were likely just trying to help, but were
unable to perceive their actions as problematic. Stigma in psychiatric healthcare leads to
biased punishments and treatments that are ineffective, painful, and emotionally
damaging.
During Lori Schiller’s first extended hospitalization, she incites the inception of
her hatred,
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“Everything about the hospital infuriated me. I didn’t know why I was there. I
didn’t know how I had gotten there. All I knew was that I was trapped. I felt like a
prisoner doing my time. I looked out the window every single day and waited for
my freedom. Outside was so inviting. I begged for a walk on the hospital grounds.
I was always so grateful for outside air. I hated being locked up… I wanted to get
out to be normal again” (Schiller, 1996).
There are a few very concerning remarks within this passage that tell me that Lori was
not receiving the most effective care. First, she did not understand how she had gotten to
the hospital. No one took the time to explain to her the mental illness is very real
sickness, and that was the cause of her suffering, not her actions. Second, no one
explained to her that this was essentially her new normal. Without this information, it is
easy to assess why Lori loathed the hospital from the start.
After her third suicide attempt, Lori was hospitalized for the second time. Upon
her second hospitalization, Lori was very ill. Her Voices were in complete control. She
recites that from the very first days, the days inside the hospital here “painfully empty.”
She saw a psychiatrist three times a week: “I didn’t like my doctor I was assigned. He
didn’t understand me. I didn’t care if I understood him or not. So our sessions were a
dreary waste of time” (Schiller, 1996). Lori let her Voices run the show during this
hospitalization. She began cheeking her medicine, i.e. not swallowing it and made
frequent visits to her memoir’s namesake, The Quiet Room. She describes her idea of the
room in great detail,
“The Quiet Room was supposed to be a safe and tranquil place, a place where
patients could be alone, free to relax and calm themselves down after a crisis.
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Some walked in voluntarily… Me, I was usually carried there. I hated it. It was
almost a routine. I’d hear the Voices, would feel the need to do something
destructive, and be sentenced to the Quiet Room” (Schiller, 1996).
When Lori was in the Quiet Room her voices went wild:
“Far from calming me down, the very emptiness of the Quiet Room became the
screen on which terrible fantasy projected itself. The Voices spoke to me through
cracks and vents in the walls. The overhead light transmitted messages to me. I
couldn’t breathe. My skull was coming undone and the Voices became
megaphoned until I was sure they would deafen me. I had to make them stop. I
had superhuman energy, superhuman strength. I literally punched a hole in the
wall. I pounded my hands across the safety screen on the windows, opening my
knuckles and fingers till the bones showed, and blood ran down my arms. I was
beyond even the Quiet Room” (Schiller, 1996).
This passage is perhaps the most disturbing that Lori shares. It is literally terrifying,
absolutely hair-raising. Nevertheless, the punishment she received from these actions is
almost scarier,
“I was going to be cold-wet-packed… The idea behind cold wet packs was to chill
the patient thoroughly. As the body struggled to warm itself, it would use energy.
And as the person tired from the effort to get warm, he or she would calm down,
ultimately relax, and, it was hoped, fall asleep. I was wrapped securely in sheets
that had been soaking in ice water. They wrapped me tight as a mummy… Cold
pack protocol mandated a full two hours as this freezing mummy. When the two
hours we up, a decision had to be made. Was I calm enough to be unpacked? If
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not, an order had to be made for an additional two hours. After the two hours were
up, I had usually recovered enough of myself to be self-conscious about what had
transpired… I’d be freezing, wet and cramped, and feeling embarrassed, degraded
and demeaned by the whole process” (Schiller, 1996).
While Lori was violent and undoubtedly needed to be calmed down, why was, what I
would consider a form of torture, used as a punishment for someone who was so terrified
of everything around her? The idea was not only ineffective, as she cites more than one
cold-packing, but degrading in such a way that reiterated that her psychosis made her
different, more violent than others, thus worsening self stigma, self-esteem, and pushing
her deeper in psychosis. The health care that was supposed to help her, made everything
much worse.
Elyn Saks’s first stay in an American psychiatric hospital also harkens images of
medieval torture. She chronicles her horror,
“Within seconds, The Doctor and his team of goons swooped down, grabbed me,
lifted me out of the chair, and slammed me down on a nearby bed with such force
that I saw stars. Then they bound both my legs and arms to the metal bed with
thick leather straps.” Next, they forced medicine down her throat, and as you can
imagine this was a terrifying and belittling experience. The next day she was
forced into restraints once more to which she recounts, “No single hallucination,
no threat of demonic forces or impulses I couldn’t control had ever held me
hostage like this. No one I knew, no one who ever loved me, knew that I was
here, tied to a bed with a net over my body. I was alone in the night, with evil
coming at me both from within myself and from without. It was unimaginable to
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me at that point that the ancient meaning of the word ‘hospital’ is ‘shelter.’
Refuge. Comfort. Care. No” (Saks, 2007).
She pleaded with her doctors about her detest for the restraints. “Please, I’ll do
anything.” The doctors persisted, citing that she was very psychotic. She brilliantly
defends in The Center Cannot Hold, “If they couldn’t tolerate what was in my head, why
were any of them in this business?”
Fortunately, Elyn was able to take her frightening experience and do something
about it. She wrote a Note for The Yale Law Journal inciting a beautiful argument. The
Note first establishes,
“A patient should be deprived of his liberty only when failure to do so either
presents a risk of serious physical harm to himself or others or prevents medical
treatment which has clearly been shown to be effective. Second, a patient should
be deprived of his liberty only to the extent necessary to achieve the desired goal.
Third, a patient’s right to choose among treatments should be protected whenever
possible. Fourth, when a patient must be deprived of liberty, a set of strict
procedures should be imposed to ensure that the infringements upon his liberty
and dignity will be kept to an absolute minimum. The law’s current treatment of
restraints substantially departs” (Saks, 1986).
Not only does she flawlessly establish the rights of individuals with mental illness, her
counterarguments are perceptive, concise, and perfect. For example, she takes down the
argument that psychiatric patients cannot appreciate their actions in the same why that
other individuals can, meaning we should therefore be less concerned about protecting
their liberty by instancing two reasons. The first is that nothing even remotely suggests
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that psychiatric patients value their freedom as least as much as anyone else does. Second
she establishes that creating a “standard of liberty based upon an individual’s level of
functioning” would open pandora’s box about the weights and merits of the liberties of
different individuals within society. Elyn argues that rather than having to ask ourselves
these questions, we must ensure that these individuals maintain the little freedom they
have while also giving them a right to choose how they are treated (Saks, 1986).
The Note continues by advancing on medical professionals, “The physician's
superior medical knowledge does not vest him with a unique ability to make these
collective, ethical choices. The questions are properly social, not medical, and the
answers should be properly supplied by social mechanisms” (Saks, 1986). Elyn brilliantly
makes clear that holding someone in restraints is not a medical issue but a violation of
human rights that must be addressed by legislation. Elyn remarks in The Center Cannot
Hold that lawyers have used her note as inspiration to create lawsuits that challenge the
use of restraints. Elyn’s determination and brilliance is incredible, and her fight against
stigma in mental illness had only just begun with this note.
Today cold packing has, thankfully, fallen out of favor and is no longer used as
treatment. However, in a 2010 paper affiliated with Harvard medical school, “concerns of
patient safety” are cited first for justified use of restraints. While safety is a legitimate
concern, as patients who are severely ill can remove IVs and the like, I would question
how often someone on a psychiatric ward would have an IV? This article also cites staff
safety as a concern, but I must bring back Elyn’s words that question why someone
would work in this environment if they are not trained to deal with the minds and actions
of the mentally ill? Lori and Elyn’s experiences with psychiatric healthcare are
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indefensible. No human should ever undergo such treatment. To further prevent this from
happening to others, society must take our prior, ineffective policies and use their torment
as implementation of education and change.
The Sun will Rise: Conclusion
While there are plenty of issues that continue to persecute the mentally ill,
particularly those with schizophrenia, I must mention that there are plenty of reasons to
hope. This disease was once regarded as being possessed by demons, and while I am sure
that Elyn, Lori, or Kurt would not argue against that when their illnesses were at their
worst, we now understand that it is a brain disease, one of broken connectivity. This
discovery alone has allowed treatment to be revitalized in nearly every aspect: from
electroshock and psychoanalysis to antipsychotics, cognitive behavioral therapy, assertive
community treatment, etc. Being able to control symptoms with more effective treatment
methods means that societal issues that individuals with schizophrenia are forced to bare,
namely stigma, can be researched and further understood. Education can be provided to
the masses, ensuring inaccurate beliefs, opinions, and interpretations are corrected-putting an end to the plight of stigma.
The Ever After
I must conclude the stories that I have shared throughout. Thus far, I have shared
mostly the low points from the memoirs of Elyn, Lori, and Kurt. To be fair, the majority
of the pages of these books are rife with madness, struggle, and strife. Nevertheless, each
author includes an epilogue, the final chapter of hope.
After Elyn’s break in law school she went on to find her passion in mental health
law, as evidenced by her note on restraints. That note was the beginning of something
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wonderful for Elyn. After establishing that working at a stressful law firm was not ideal
for her, Elyn began to teach law. Today, Elyn teaches at USC Law School where she has
achieved tenure. She continues to educate others on living with schizophrenia. Of her
recovery Elyn shares,
“My life today is not without its troubles. I have a major mental
illness. I will never fully recover from schizophrenia. I will always need to
be on antipsychotic medication and in talk therapy. I will always have
good days and bad, and I still get sick.
But the treatment I have received has allowed me a life I consider
wonderfully worth living. My good fortune is not that I’ve recovered from
mental illness. I have not, nor will I ever. My good fortune lies in having
found my life” (Saks, 2007).
Lori Schiller lost everything in the midst of her illness. Therefore, she faced a
long recovery. She had to recreate her life in almost every respect: losing the inherent
fear of people was the top priority, followed by learning to be social, then taking on
budgeting, cooking, cleaning, even taking her medications on her own. She recognizes
that the process took a while, and she spent three years in a halfway house to gain the
skills she needed to live on her own. Interestingly, Lori touches on what it was like to live
without the Voices that were so cruel to her for so long. She recalls, “I found to my
surprise that I missed them… My head felt empty. Without them I felt lonely… The
Voices had dominated my head for so long that they had left no room for any other
thoughts” (Schiller, 1996). This I found completely heartbreaking. Lori had become a
victim of Stockholm syndrome. Nevertheless, with the help of support groups and
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counselors Lori was able to create a life without the Voices. Today, Lori works at an
outpatient treatment center, she notes that she is a staff member who understands both
sides of the fence. Lori lives happily in Florida with her husband.
Kurt Snyder recognizes that medications have helped him reclaim his life from
the depths of paranoid psychosis. On his recovery he reports,
“The improvement in my mental health status has been gradual but continuous,
and I have not had any clinical symptoms of schizophrenia for at least four years.
I also seem to be progressing in in other ways that are not easily classified by a
doctor. My productivity and outlook on life all seem to improve as time passes.
Most people who meet me now would find it hard to believe that I ever had a
mental illness. Many are surprised when I tell them I have schizophrenia”
(Snyder, 2007).
Kurt continues by citing the importance of social support in his recovery: “Most of my
friends and family who knew about my mental problems were still very close to me--they
never abandoned me. This was truly a blessing” (Snyder, 2007). Today Kurt works as a
database administrator and president of his volunteer fire department in Maryland.
Aunt Linda
After reading the testimonies of Elyn, Lori, and Kurt and upon my visit with my
Aunt Linda, I began to wonder about the details of her life. When did she first show signs
of illness? Did she experience a dramatic psychotic break? Upon talking with her sister
Carol, my Auntie Carol, I began to puzzle the pieces of her life together. She was
apparently always “odd” in childhood, consistently speaking of a ghost around their
home she named Alabaster. She went on to study business at Ball State University, but
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became delusional in her third year with regards to a certain professor whom she had
apparently fallen in love with. She returned home, believing that he would follow her.
She lived at home with her mother for a while before moving away again. Naturally, she
was never able to hold down a job, so she was forced to returned home to live with her
mother once more. It was around this time when she received her diagnosis. Interestingly,
but not really surprising, is the fact that the doctor had to make a house call, as she
refused to go to the hospital defending, “there was nothing wrong with her.” Eventually
she was able to move into a small apartment on her own in town after my Grandma
Hawkins had taken ill. Throughout this time period she was not on antipsychotics or
receiving any treatment. Consequently, her delusions ran wild. She brought Christmas
presents for her deceased father during the holidays and firmly believed her mother to be
dead, when in reality Grandma Hawkins was suffering from severe Parkinson's.
Nevertheless, my Auntie Carol continued to manage her finances and take her to get
groceries with her every Saturday. I would often join them on their trips to the grocery. In
fact, some of my very earliest memories are grocery shopping with Auntie Carol and
Aunt Linda at the JayC food store in Paoli, IN.
Aunt Linda continued to live in her small apartment in Paoli for many years. She
apparently had consistent catatonic spells, only occasionally going outside to walk or
interact with others. As I previously mentioned, she was not taking antipsychotics, and
she lived alone. While this somehow worked out for several years, her symptoms
inevitably began to flare. My Auntie Carol would get calls from neighbors that she had,
without invite, walked into their house and was rummaging through their belongings.
These symptomatic flare ups kept happening, and Auntie Carol was forced to have her
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committed to the psych ward in nearby Jasper, IN. From there she was relocated to her
current group home. She is now on a steady regimen of antipsychotics and lives in a
place where she is surrounded by others. She also joins the family on Christmas and
Thanksgiving and sends each of her six nieces and nephews a birthday card every year.
While Aunt Linda’s life is probably much better than before, I wonder what other
symptoms she might have suffered from. Did she endure threatening, evil voices? Did
she ever fear for her life due to incessant paranoia? I have only visited her one time in the
13 years that she has lived in Jasper. Two of her siblings visit occasionally but not often.
I am saddened that she lives a very lonely life, duely filled with boredom. Therefore, I
think I have a responsibility to begin making it a priority to visit her more often with my
Auntie Carol. We can rekindle our conversation on Plato and Aristotle, or maybe just
discuss the plot of a Danielle Steel novel. It is my duty, now that I consider myself
somewhat of an expert on Aunt Linda’s illness, to correct the insensitivities from the rest
of my countrified, Southern Indiana family. Linda is not “batshit crazy.” She is mentally
ill and deserves respect from each of us. Because when someone sends a birthday card
every year, they are not crazy. They care. The least we can do is the same.
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